Date Field | Doc. No. | Description (Pages) |
---|
Jan 27, 2021 | 303 | MANDATE of USCA for the Federal Circuit as to 294 Notice of Appeal filed by APOTEX, INC. (Federal Circuit Appeal #2020-1328) (LBT) (Entered: 01/27/2021) (1) |
Dec 21, 2020 | 302 | JUDGMENT and OPINION of Federal Circuit of the USCA as to 294 Notice of Appeal filed by APOTEX, INC. (USCA #2020-1328) - THIS CAUSE having been considered, it is ORDERED AND ADJUDGED: AFFIRMED. (LBT) (Entered: 12/21/2020) (12) |
Jan 22, 2020 | 301 | NOTICE of Change of Attorney Information. Consistent with Local Rule 5-3, Adam L. Perlman hereby notifies the Clerk of the court of changed contact information. (Perlman, Adam) (Entered: 01/22/2020) (1) |
Jan 7, 2020 | 300 | USCA for the Federal Circuit Case Number 2020-1328 for 294 Notice of Appeal filed by APOTEX, INC. (LBT) (Entered: 01/07/2020) (3) |
Jan 6, 2020 | 298 | NOTICE of Final Determination in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Final Judgment) (NAD) (Entered: 01/06/2020) (0) |
Jan 6, 2020 | 299 | NOTICE of Appeal in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Notice of Appeal) (NAD) (Entered: 01/06/2020) (0) |
Dec 31, 2019 | 294 | NOTICE OF APPEAL as to 293 Closed Judgment, 292 Terminate Deadlines and HearingsEntryTerminate Motions, filed by Counter Claimant APOTEX, INC., Defendant APOTEX, INC.. (Filing fee $505, receipt number 0756-5788929) (Zweig, Sally) (Entered: 12/31/2019) (3) |
Dec 31, 2019 | 295 | ***PLEASE DISREGARD - DOCKETED IN ERROR *** PARTIES' SHORT RECORD re 294 Notice of Appeal - Instructions for Attorneys/Parties attached. (RSF) Modified on 12/31/2019 (RSF). (Entered: 12/31/2019) (30) |
Dec 31, 2019 | 296 | ***PLEASE DISREGARD - DOCKETED IN ERROR*** Transmission of Notice of Appeal and Docket Sheet to US Court of Appeals re 294 Notice of Appeal. - for Court of Appeals Use Only. (RSF) Modified on 12/31/2019 (RSF). (Entered: 12/31/2019) (30) |
Dec 31, 2019 | 297 | FEDERAL CIRCUIT APPEAL INFORMATION SHEET re 294 Notice of Appeal - Parties' Short Record attached. Copy sent to Federal Circuit Court of Appeals via email. (RSF) (Entered: 12/31/2019) (30) |
Dec 31, 2019 | 294 | Notice of Appeal* (1) |
Dec 30, 2019 | 292 | ENTRY ON CROSS-MOTIONS FOR SUMMARY JUDGMENT - For the reasons stated above, the Court GRANTS Lilly's Motion for Summary Judgment on its infringement claim (Filing No. 231 ) and DENIES Apotex's Motion for Summary Judgment (Filing No. 254 ). The filing of NDA No. 210661 by Apotex infringes the '209 patent. Pursuant to 35 U.S.C. 271(e)(4)(A), the effective approval date of any product that is the subject of Apotex's NDA No. 210661 shall be not earlier than the latest date of expiration of the '209 patent, including any extensions of the period of exclusivity.All other pending motions (Filing No. 198 ; Filing No. 250 ) are denied as moot. The trial and final pretrial conference are hereby vacated. Final judgment will issue under separate order. (See Entry.). Signed by Judge Tanya Walton Pratt on 12/30/2019.(NAD) (Entered: 12/30/2019) (14) |
Dec 30, 2019 | 293 | FINAL JUDGMENT PURSUANT TO FED. R. CIV. PRO. 58 - The Court having this day made its Entry directing the entry of final judgment, now enters FINAL JUDGMENT. Judgment is entered in favor of Plaintiff Eli Lilly and Company ("Lilly") and against Defendant Apotex, Inc. ("Apotex"). The filing of NDA No. 210661 by Apotex infringed at least claims 9, 10, 12, 13, 14, 15, 18, 19, 21, and 22 of Lilly's U.S. Patent No. 7,772,209 ("the '209 patent"), and those claims have not been proven invalid. Pursuant to 35 U.S.C. 271(e)(4)(A), the effective approval date of any product that is the subject of NDA No. 210661 shall be not earlier than the latest date of expiration of the '209 patent, including any extensions of the period of exclusivity. JUDGMENT IS ENTERED in favor of Lilly and against Apotex. Signed by Judge Tanya Walton Pratt on 12/30/2019.(NAD) (Entered: 12/30/2019) (2) |
Dec 23, 2019 | 291 | ENTRY ON CLAIM CONSTRUCTION - For these reasons set forth above, the disputed claim terms and phrases have the following meanings: (See Entry) The clerk is directed to terminate the gavel at dkt. 132. Signed by Judge Tanya Walton Pratt on 12/23/2019.(NAD) (Entered: 12/23/2019) (25) |
Dec 16, 2019 | 290 | ORDER - The Court, on its own motion, RESCHEDULES the Section IX.A and Section IX.B Case Management Plan deadlines. The Section IX.A deadline (2 week filings) is now December 30, 2019. The Section IX.B deadline (1 week filings) is now January 6, 2020. This matter remains set for Final Pretrial on January 8, 2020 at 2:00 p.m. and Bench Trial on January 13, 2020 at 9:00 a.m. Copies to Annie E. Showalter and Benjamin Greenblum via US Mail. Signed by Judge Tanya Walton Pratt on 12/16/2019.(NAD) Modified on 12/16/2019 (NAD). (Entered: 12/16/2019) (3) |
Nov 14, 2019 | 289 | ORDER - GRANTING 288 JOINT MOTION TO ADJUST CASE MANAGEMENT PLAN. It is hereby ORDERED that the final pretrial conference set for December 18, 2019 is VACATED. The final pretrial conference is RESCHEDULED to January 8, 2020 at 2:00 p.m. in Room 330. (See Order.) Signed by Judge Tanya Walton Pratt on 11/14/2019.(NAD) (Entered: 11/14/2019) (1) |
Nov 13, 2019 | 288 | Joint MOTION to Amend Case Management Plan, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 11/13/2019) (0) |
Oct 22, 2019 | 287 | REPLY in Support of Motion re 250 MOTION to Strike 232 SEALED Document (Case Participants - doc) Apotexs Motion to Strike Dr. Chabners Patent Prosecution and Examination Opinions , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/22/2019) (11) |
Oct 18, 2019 | 286 | ORDER granting 283 Motion to Maintain Document 282 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 10/18/2019. (JRB) (Entered: 10/18/2019) (1) |
Oct 15, 2019 | 282 | SEALED REPLY in support of Motion re 254 Cross MOTION for Summary Judgment APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/15/2019) (0) |
Oct 15, 2019 | 283 | MOTION to Maintain Document Under Seal 282 SEALED Reply in support of Motion APOTEXS MOTION TO FILE AND MAINTAIN REPLY IN SUPPORT OF APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 10/15/2019) (0) |
Oct 15, 2019 | 284 | BRIEF/MEMORANDUM in Support re 283 MOTION to Maintain Document Under Seal 282 SEALED Reply in support of Motion APOTEXS MOTION TO FILE AND MAINTAIN REPLY IN SUPPORT OF APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/15/2019) (5) |
Oct 15, 2019 | 285 | REDACTION to 282 SEALED Reply in support of Motion REPLY IN SUPPORT OF APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT by APOTEX, INC.. (Attachments: # 1 Exhibit 1 (Corrected and Updated Appendix to Apotex's Motion for Summary Judgment), # 2 Exhibit Appendix - SJ2538-2560 (Vol 15))(Zweig, Sally) (Entered: 10/15/2019) (0) |
Oct 11, 2019 | 280 | ORDER granting 275 Motion to Maintain Document 274 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 10/11/2019. (JRB) (Entered: 10/11/2019) (1) |
Oct 11, 2019 | 281 | ORDER granting 273 Motion to Maintain Document 272 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 10/11/2019. (JRB) (Entered: 10/11/2019) (1) |
Oct 10, 2019 | 276 | BRIEF/MEMORANDUM in Support re 275 MOTION to Maintain Document Under Seal 274 SEALED Response to Motion for Summary Judgment , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/10/2019) (5) |
Oct 10, 2019 | 277 | REDACTION to 274 SEALED Response to Motion PLAINTIFFS REPLY IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT AND RESPONSE IN OPPOSITION TO DEFENDANTS MOTION FOR SUMMARY JUDGMENT by APOTEX, INC.. (Attachments: # 1 Appendix REDACTED - MARK J. RATAIN, M.D. Deposition)(Zweig, Sally) (Entered: 10/10/2019) (0) |
Oct 10, 2019 | 278 | BRIEF/MEMORANDUM in Support re 273 MOTION to Maintain Document Under Seal 272 SEALED Response to Motion to Strike APOTEXS BRIEF IN SUPPORT OF LILLYS MOTION TO FILE AND MAINTAIN UNDER SEAL LILLYS RESPONSE IN OPPOSITION TO APOTEXS MOTION TO STRIKE, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/10/2019) (5) |
Oct 10, 2019 | 279 | REDACTION to 272 SEALED Response to Motion PLAINTIFF ELI LILLY AND COMPANYS RESPONSE IN OPPOSITION TO DEFENDANT APOTEX INC.S MOTION TO STRIKE by APOTEX, INC.. (Zweig, Sally) (Entered: 10/10/2019) (10) |
Oct 1, 2019 | 272 | SEALED RESPONSE re 250 MOTION to Strike 232 SEALED Document (Case Participants - doc) Apotexs Motion to Strike Dr. Chabners Patent Prosecution and Examination Opinions , filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 10/01/2019) (0) |
Oct 1, 2019 | 273 | MOTION to Maintain Document Under Seal 272 SEALED Response to Motion to Strike, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 10/01/2019) (0) |
Oct 1, 2019 | 274 | SEALED RESPONSE re 254 Cross MOTION for Summary Judgment APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Appendix (A769-A810))(Perlman, Adam) (Entered: 10/01/2019) (0) |
Oct 1, 2019 | 275 | MOTION to Maintain Document Under Seal 274 SEALED Response to Motion for Summary Judgment, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Perlman, Adam) (Entered: 10/01/2019) (0) |
Sep 30, 2019 | 270 | SEALED , re 255 SEALED Response to Motion, filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix Appendix SEALED Vol 14 (SJ2408-2537))(Zweig, Sally) (Entered: 09/30/2019) (0) |
Sep 30, 2019 | 271 | REDACTION to 258 Redacted Document by APOTEX, INC.. (Attachments: # 1 Appendix Appendix REDACTED Vol 14 (SJ2408-2537))(Zweig, Sally) (Entered: 09/30/2019) (0) |
Sep 23, 2019 | 269 | ORDER - granting 268 Motion to Withdraw Attorney Appearance. IT IS, THEREFORE, ORDERED that the appearance of Galina I. Fomenkova is withdrawn in this matter. Signed by Judge Tanya Walton Pratt on 9/23/2019. (NAD) (Entered: 09/23/2019) (1) |
Sep 20, 2019 | 268 | MOTION to Withdraw Attorney Appearance of Galina I. Fomenkova, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 09/20/2019) (0) |
Sep 10, 2019 | 267 | ORDER - GRANTING JOINT 266 MOTION REGARDING BRIEFING SCHEDULE. Lilly's Response to Apotex's Motion to Strike Dr. Chabner's Patent Prosecution and Examination Opinions (ECF 250 ) shall be due on October 1, 2019. Apotex's Reply in Support of its Motion to Strike Dr. Chabner's Patent Prosecution and Examination Opinions shall be due on October 22, 2019. Signed by Judge Tanya Walton Pratt on 9/10/2019. (NAD) (Entered: 09/11/2019) (1) |
Sep 9, 2019 | 266 | Joint MOTION for Extension of Time to 10/1/2019 (Response); 10/22/2019 (Reply) in which to 250 MOTION to Strike 232 SEALED Document (Case Participants - doc) Apotexs Motion to Strike Dr. Chabners Patent Prosecution and Examination Opinions , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 09/09/2019) (0) |
Sep 5, 2019 | 264 | ORDER granting 259 Motion to Maintain Document 258 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 9/5/2019. (JRB) (Entered: 09/05/2019) (1) |
Sep 5, 2019 | 265 | ORDER granting 256 Motion to Maintain Document 255 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 9/5/2019. (JRB) (Entered: 09/05/2019) (1) |
Sep 4, 2019 | 259 | MOTION to Seal Document 258 Redacted Document , filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 09/04/2019) (0) |
Sep 4, 2019 | 260 | REDACTION to 258 Redacted Document by APOTEX, INC.. (Zweig, Sally) (Entered: 09/04/2019) (30) |
Sep 4, 2019 | 261 | ORDER granting 240 Motion to Maintain Document 239 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 9/4/2019. (JRB) (Entered: 09/04/2019) (1) |
Sep 4, 2019 | 262 | ORDER granting 244 Motion to Maintain Document 243 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 9/4/2019. (JRB) (Entered: 09/04/2019) (1) |
Sep 4, 2019 | 263 | ORDER granting 252 Motion to Maintain Document 251 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 9/4/2019. (JRB) (Entered: 09/04/2019) (1) |
Aug 30, 2019 | 249 | MARGINAL ENTRY - Acknowledging 248 Joint Stipulation Regarding Claims and Defenses. Signed by Judge Tanya Walton Pratt on 8/30/2019.(NAD) (Entered: 08/30/2019) (2) |
Aug 30, 2019 | 250 | MOTION to Strike 232 SEALED Document (Case Participants - doc) Apotexs Motion to Strike Dr. Chabners Patent Prosecution and Examination Opinions, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A (Excerpts from Bruce A. Chabner, M.D. Deposition), # 2 Exhibit B (REDACTED Excerpts from Lilly Summary Judgment Appendix), # 3 Exhibit C (REDACTED Excerpts from Bruce A. Chabner, M.D. Deposition), # 4 Text of Proposed Order)(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 251 | SEALED EXHIBITS B AND C TO APOTEXS MOTION TO STRIKE DR. CHABNERS PATENT PROSECUTION AND EXAMINATION OPINIONS, re 250 Motion to Strike, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit B (SEALED Excerpts from Lilly Summary Judgment Appendix), # 2 Exhibit C (SEALED Excerpts from Bruce A. Chabner, M.D. Deposition))(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 252 | MOTION to Maintain Document Under Seal 251 SEALED Document (Case Participants - doc) EXHIBITS B AND C TO APOTEXS MOTION TO STRIKE DR. CHABNERS PATENT PROSECUTION AND EXAMINATION OPINIONS, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 253 | BRIEF/MEMORANDUM in Support re 252 MOTION to Maintain Document Under Seal 251 SEALED Document (Case Participants - doc) EXHIBITS B AND C TO APOTEXS MOTION TO STRIKE DR. CHABNERS PATENT PROSECUTION AND EXAMINATION OPINIONS , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/30/2019) (5) |
Aug 30, 2019 | 254 | Cross MOTION for Summary Judgment APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 255 | SEALED RESPONSE re 254 Cross MOTION for Summary Judgment APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT SEALED BRIEF IN SUPPORT APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, SEALED Appendices. 8-9, 11-14, filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix to APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, # 2 Appendix SEALED Vol 8 (SJ0984-1119), # 3 Appendix SEALED Vol 9 (SJ1120-1361), # 4 Appendix SEALED Vol 11 (SJ1646-2035), # 5 Appendix SEALED Vol 12 (SJ2036-2176), # 6 Appendix SEALED Vol 13 (SJ2177-2407), # 7 Appendix SEALED Vol 14 (SJ2408-2537))(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 256 | MOTION to Maintain Document Under Seal 255 SEALED Response to Motion SEALED BRIEF IN SUPPORT APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, SEALED Appendices. 8-9, 11-14, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 08/30/2019) (0) |
Aug 30, 2019 | 257 | BRIEF/MEMORANDUM in Support re 256 MOTION to Maintain Document Under Seal 255 SEALED Response to Motion SEALED BRIEF IN SUPPORT APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, SEALED Appendices. 8-9, 11-14 , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/30/2019) (6) |
Aug 30, 2019 | 258 | REDACTION to 255 SEALED Response to Motion by APOTEX, INC.. (Attachments: # 1 Appendix APOTEXS CROSS-MOTION FOR SUMMARY JUDGMENT OF NON-INFRINGEMENT, # 2 Appendix Vol 1 (SJ0001-0115), # 3 Appendix Vol 2 (SJ0116-0204), # 4 Appendix Vol 3 (SJ0205-0366), # 5 Appendix Vol 4 (SJ0367-0479), # 6 Appendix Vol 5 (SJ0480-0562), # 7 Appendix Vol 6 (SJ0563-0767, # 8 Appendix Vol 7 (SJ0768-0983), # 9 Appendix REDACTED Vol 8 (SJ0984-1119), # 10 Appendix REDACTED Vol 9 (SJ1120-1361), # 11 Appendix Vol 10 (SJ1362-1645), # 12 Appendix REDACTED Vol 11 (SJ1646-2035), # 13 Appendix REDACTED Vol 12 (SJ2036-2176), # 14 Appendix REDACTED Vol 13 (SJ2177-2407), # 15 Appendix REDACTED Vol 14 (SJ2408-2537))(Zweig, Sally) Modified on 9/4/2019 to SEAL Main Document (TMB). (Entered: 08/30/2019) (0) |
Aug 29, 2019 | 248 | STIPULATION Regarding Claims and Defenses, filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 08/29/2019) (2) |
Aug 23, 2019 | 247 | NOTICE OF INTENT TO FILE MOTION TO LIMIT EXPERT TESTIMONY, filed by Defendant APOTEX, INC., re 218 Order on Motion to Amend/CorrectScheduling, 157 Order on Motion to Amend/CorrectScheduling. (Zweig, Sally) (Entered: 08/23/2019) (3) |
Aug 22, 2019 | 245 | BRIEF/MEMORANDUM in Support re 244 MOTION to Maintain Document Under Seal 243 SEALED Document (Case Participants - doc) Witness and Exhibit List , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/22/2019) (5) |
Aug 22, 2019 | 246 | REDACTION to 243 SEALED Document (Case Participants - doc) Lilly's Witness & Exhibit List by APOTEX, INC.. (Zweig, Sally) (Entered: 08/22/2019) (7) |
Aug 16, 2019 | 238 | ORDER GRANTING PLAINTIFF ELI LILLY AND COMPANY'S MOTION TO FILE UNDER SEAL AND PROVISIONALLY MAINTAIN UNDER SEAL PLAINTIFF'S MEMORANDUM IN SUPPORT OF MOTION FOR SUMMARY JUDGMENT AND APPENDIX THERETO - granting 235 Motion to Maintain Document Under Seal. The Court shall maintain Lilly's Memorandum in Support of Motion for Summary Judgment (Docket No. 232) and the Appendix thereto (Docket No 232-1) under seal. A redacted public version of the documents shall be available on the docket (Docket No. 237 and Docket No. 237-1). Signed by Magistrate Judge Matthew P. Brookman on 8/16/2019. (DMW) (Entered: 08/16/2019) (1) |
Aug 16, 2019 | 239 | SEALED APOTEXS WITNESS AND EXHIBIT LIST, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/16/2019) (0) |
Aug 16, 2019 | 240 | MOTION to Maintain Document Under Seal 239 SEALED Document (Case Participants - doc) APOTEXS WITNESS AND EXHIBIT LIST, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 08/16/2019) (0) |
Aug 16, 2019 | 241 | BRIEF/MEMORANDUM in Support re 240 MOTION to Maintain Document Under Seal 239 SEALED Document (Case Participants - doc) APOTEXS WITNESS AND EXHIBIT LIST , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/16/2019) (5) |
Aug 16, 2019 | 242 | REDACTION to 239 SEALED Document (Case Participants - doc) APOTEXS WITNESS AND EXHIBIT LIST by APOTEX, INC.. (Zweig, Sally) (Entered: 08/16/2019) (7) |
Aug 16, 2019 | 243 | SEALED Witness and Exhibit List, filed by Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 08/16/2019) (0) |
Aug 16, 2019 | 244 | MOTION to Maintain Document Under Seal 243 SEALED Document (Case Participants - doc) Witness and Exhibit List, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 08/16/2019) (0) |
Aug 13, 2019 | 236 | BRIEF/MEMORANDUM in Support re 235 MOTION to Maintain Document Under Seal 232 SEALED Document (Case Participants - doc) Memorandum in Support of Motion for Summary Judgment and Appendix Thereto , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/13/2019) (5) |
Aug 13, 2019 | 237 | REDACTION to 232 SEALED Document (Case Participants - doc) Lilly Memorandum in Support of Motion for Summary Judgement (REDACTED) by APOTEX, INC.. (Attachments: # 1 Appendix to Lilly's Memorandum in Support of Motion for Summary Judgement (REDACTED))(Zweig, Sally) (Entered: 08/13/2019) (0) |
Jul 30, 2019 | 230 | ORDER granting 229 Motion to Appear pro hac vice. Attorney Annie E. Showalter for ELI LILLY AND COMPANY,Annie E. Showalter for ELI LILLY AND COMPANY added. Signed by Magistrate Judge Matthew P. Brookman on 7/30/2019. (JRB) (Entered: 07/30/2019) (2) |
Jul 30, 2019 | 231 | MOTION for Summary Judgment , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Perlman, Adam) (Entered: 07/30/2019) (0) |
Jul 30, 2019 | 232 | SEALED Memorandum in Support, re 231 Motion for Summary Judgment, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Appendix (A1-A768))(Perlman, Adam) (Entered: 07/30/2019) (0) |
Jul 30, 2019 | 233 | DECLARATION of Bruce A. Chabner, M.D. re 231 Motion for Summary Judgment by ELI LILLY AND COMPANY. (Perlman, Adam) (Entered: 07/30/2019) (3) |
Jul 30, 2019 | 234 | DECLARATION of Rodolfo Pinal, Ph.D. re 231 Motion for Summary Judgment by ELI LILLY AND COMPANY. (Perlman, Adam) (Entered: 07/30/2019) (2) |
Jul 30, 2019 | 235 | MOTION to Maintain Document Under Seal 232 SEALED Document (Case Participants - doc) Memorandum in Support of Motion for Summary Judgment and Appendix Thereto, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Perlman, Adam) (Entered: 07/30/2019) (0) |
Jul 29, 2019 | 229 | MOTION for Attorney(s) Annie E. Showalter to Appear pro hac vice (Filing fee $100, receipt number 0756-5551039), filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit A - Certification of Annie E. Showalter, # 2 Text of Proposed Order Granting Motion to Appear Pro Hac Vice)(Pollack-Milgate, Deborah) (Entered: 07/29/2019) (0) |
Jul 23, 2019 | 228 | ORDER granting 222 Motion to Maintain Document 221 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 7/23/2019. (JRB) (Entered: 07/23/2019) (1) |
Jul 19, 2019 | 227 | ORDER granting 220 Motion to Maintain Document [219[ Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 7/19/2019. (JRB) (Entered: 07/19/2019) (1) |
Jul 17, 2019 | 225 | BRIEF/MEMORANDUM in Support re 220 MOTION to Maintain Document Under Seal 219 SEALED Document (Case Participants - doc) Statement of Claims and Defenses APOTEXS BRIEF IN SUPPORT OF LILLYS MOTION TO FILE AND MAINTAIN UNDER SEAL LILLYS STATEMENT OF CLAIMS AND DEFENSES, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 07/17/2019) (5) |
Jul 17, 2019 | 226 | REDACTION to 219 SEALED Document (Case Participants - doc) LILLYS STATEMENT OF CLAIMS AND DEFENSES by APOTEX, INC.. (Zweig, Sally) (Entered: 07/17/2019) (11) |
Jul 9, 2019 | 219 | SEALED Statement of Claims and Defenses, filed by Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 07/09/2019) (0) |
Jul 9, 2019 | 220 | MOTION to Maintain Document Under Seal 219 SEALED Document (Case Participants - doc) Statement of Claims and Defenses, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 07/09/2019) (0) |
Jul 9, 2019 | 221 | SEALED Apotex, Inc.'s Statement of Claims and Defenses, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 07/09/2019) (0) |
Jul 9, 2019 | 222 | MOTION to Maintain Document Under Seal 221 SEALED Document (Case Participants - doc) Apotex, Inc.'s Statement of Claims and Defenses, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 07/09/2019) (0) |
Jul 9, 2019 | 223 | BRIEF/MEMORANDUM in Support re 222 MOTION to Maintain Document Under Seal 221 SEALED Document (Case Participants - doc) Apotex, Inc.'s Statement of Claims and Defenses , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 07/09/2019) (5) |
Jul 9, 2019 | 224 | REDACTION to 221 SEALED Document (Case Participants - doc) Apotex, Inc.'s Statement of Claims and Defenses by APOTEX, INC.. (Zweig, Sally) (Entered: 07/09/2019) (11) |
Jun 26, 2019 | 218 | ORDER - GRANTING 217 MOTION TO ADJUST CASE MANAGEMENT PLAN. It is hereby ORDERED that the following deadlines in the case management plan areadjusted accordingly: Lilly SJ Motion due Jul. 30, 2019. (See Order for remaining dates.) Signed by Judge Tanya Walton Pratt on 6/26/2019.(NAD) (Entered: 06/26/2019) (1) |
Jun 25, 2019 | 217 | MOTION to Amend/Correct 157 Order on Motion to Amend/CorrectScheduling, 32 Order: Case ManagementSet Deadlines/Hearings, 127 Order on Motion to Amend/Correct, 107 Order on Motion to Amend/CorrectScheduling , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 06/25/2019) (0) |
Jun 14, 2019 | 216 | ORDER granting 212 Motion to Maintain Document Under Seal 204 SEALED Response to Motion. Signed by Magistrate Judge Matthew P. Brookman on 6/14/2019. (JRB) (Entered: 06/14/2019) (2) |
Jun 13, 2019 | 215 | ORDER granting 208 Motion to Maintain Document 207 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 6/13/2019. (JRB) (Entered: 06/13/2019) (1) |
Jun 10, 2019 | 212 | MOTION to Maintain Document Under Seal 204 SEALED Response to Motion [APOTEX'S RENEWED MOTION TO FILE AND MAINTAIN UNDER SEAL LILLY'S RESPONSE TO APOTEX'S MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW], filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 06/10/2019) (0) |
Jun 10, 2019 | 213 | BRIEF/MEMORANDUM in Support re 212 MOTION to Maintain Document Under Seal 204 SEALED Response to Motion [APOTEX'S RENEWED MOTION TO FILE AND MAINTAIN UNDER SEAL LILLY'S RESPONSE TO APOTEX'S MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF L , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 06/10/2019) (5) |
Jun 10, 2019 | 214 | REDACTION to 204 SEALED Response to Motion [PLAINTIFF ELI LILLY AND COMPANY'S RESPONSE TO DEFENDANT APOTEX INC.'S MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW] by APOTEX, INC.. (Zweig, Sally) (Entered: 06/10/2019) (8) |
Jun 7, 2019 | 211 | ORDER denying with leave to refile 205 Motion to Maintain Document Under Seal 204 SEALED Response to Motion. Plaintiff identified Defendant as the designating party pursuant to Local Rule 5-11(d)(2)(A)(ii), but Defendant has not complied with Local Rule 5-11(d)(3). Pursuant to Local Rule 5-11(g), the Clerk is DIRECTED to unseal the document 21 days after this Entry, unless a renewed motion is filed to maintain the document under seal. Signed by Magistrate Judge Matthew P. Brookman on 6/7/2019. (TMB) (Entered: 06/07/2019) (2) |
May 30, 2019 | 207 | SEALED REPLY IN SUPPORT OF APOTEXS MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW, re 198 SEALED Motion (Case Participants - doc), filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 05/30/2019) (0) |
May 30, 2019 | 208 | MOTION to Maintain Document Under Seal 207 SEALED Document (Case Participants - doc) REPLY IN SUPPORT OF APOTEXS MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 05/30/2019) (0) |
May 30, 2019 | 209 | BRIEF/MEMORANDUM in Support re 208 MOTION to Maintain Document Under Seal 207 SEALED Document (Case Participants - doc) REPLY IN SUPPORT OF APOTEXS MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 05/30/2019) (5) |
May 30, 2019 | 210 | REDACTION to 207 SEALED Document (Case Participants - doc) REPLY IN SUPPORT OF APOTEXS MOTION FOR LEAVE TO AMEND PROPOSED FINDINGS OF FACT AND CONCLUSIONS OF LAW by APOTEX, INC.. (Zweig, Sally) (Entered: 05/30/2019) (7) |
May 24, 2019 | 206 | ORDER granting 199 Motion to Maintain Document Under Seal 198 SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law. Signed by Magistrate Judge Matthew P. Brookman on 5/24/2019. (JRB) (Entered: 05/24/2019) (1) |
May 23, 2019 | 204 | SEALED RESPONSE re 198 SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law , filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 05/23/2019) (0) |
May 23, 2019 | 205 | MOTION to Maintain Document Under Seal 204 SEALED Response to Motion for Leave to Amend Proposed Findings of Fact and Conclusions of Law, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 05/23/2019) (0) |
May 20, 2019 | 203 | ORDER - GRANTING 202 JOINT MOTION TO ADJUST CASE MANAGEMENT PLAN. Upon consideration of the Joint Motion to Adjust Case Management Plan, the Motion is GRANTED. It is hereby ORDERED that the following deadline in the case management plan is extended accordingly: Reply Expert Reports DUE May 31, 2019. Signed by Judge Tanya Walton Pratt on 5/20/2019. (NAD) (Entered: 05/21/2019) (1) |
May 17, 2019 | 202 | Joint MOTION to Amend/Correct 157 Order on Motion to Amend/CorrectScheduling, 32 Order: Case ManagementSet Deadlines/Hearings, 127 Order on Motion to Amend/Correct, 107 Order on Motion to Amend/CorrectScheduling , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 05/17/2019) (0) |
May 9, 2019 | 198 | SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit SEALED Redline of Amended Proposed Findings of Fact and Conclusions of Law, # 2 Exhibit SEALED Clean of Amended Proposed Findings of Fact and Conclusions of Law, # 3 Exhibit A-Second Ratain Report (3/18/2019), # 4 Exhibit B-Second Buckton Report (3/18/2019), # 5 Exhibit C- Greenspan Report (3/18/2019), # 6 Exhibit D-First Ratain Report (3/18/2019), # 7 Exhibit E-First Buckton Report (3/18/2019), # 8 Exhibit F-Arnold Report (3/18/2019), # 9 Exhibit G-Chabner Report (5/1/19), # 10 Text of Proposed Order)(Zweig, Sally) (Entered: 05/09/2019) (0) |
May 9, 2019 | 199 | MOTION to Maintain Document Under Seal 198 SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law , filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 05/09/2019) (0) |
May 9, 2019 | 200 | BRIEF/MEMORANDUM in Support re 199 MOTION to Maintain Document Under Seal 198 SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 05/09/2019) (6) |
May 9, 2019 | 201 | REDACTION to 198 SEALED MOTION for Leave to Amend Proposed Findings of Fact and Conclusions of Law by APOTEX, INC.. (Attachments: # 1 Exhibit REDACTED Redline Proposed Amended Findings of Fact and Conclusions of Law, # 2 Exhibit REDACTED Clean Proposed Amended Findings of Fact and Conclusions of Law, # 3 Exhibit A- REDACTED Second Ratain Report (3/18/2019), # 4 Exhibit B-REDACTED Second Buckton Report (3/18/2019), # 5 Exhibit C- REDACTED Greenspan Report (3/18/2019), # 6 Exhibit D-REDACTED First Ratain Report (3/18/2019), # 7 Exhibit E-REDACTED First Buckton Report (3/18/2019), # 8 Exhibit F-REDACTED Arnold Report (3/18/2019), # 9 Exhibit G- REDACTED Chabner Report (5/1/19))(Zweig, Sally) (Entered: 05/09/2019) (0) |
May 3, 2019 | 197 | ORDER granting 196 Motion to Appear pro hac vice. Attorney Benjamin Greenblum for ELI LILLY AND COMPANY,Benjamin Greenblum for ELI LILLY AND COMPANY added. Copy sent to counsel via US Mail. Signed by Magistrate Judge Matthew P. Brookman on 5/3/2019. (JRB) (Entered: 05/03/2019) (1) |
May 2, 2019 | 196 | MOTION for Attorney(s) Benjamin Greenblum to Appear pro hac vice (Filing fee $100, receipt number 0756-5410446), filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit A - Certification of Benjamin Greenblum in Support of Motion to Appear Pro Hac Vice, # 2 Text of Proposed Order Granting Motion to Appear Pro Hac Vice)(Pollack-Milgate, Deborah) (Entered: 05/02/2019) (0) |
Apr 24, 2019 | 195 | ORDER - granting 194 Joint Motion to Adjust Case Management Plan. It is hereby ORDERED that the following deadline in the case management plan is extended accordingly: Responsive Expert Deadline from April 26, 2019 to May 1, 2019. Signed by Judge Tanya Walton Pratt on 4/24/2019. (NAD) (Entered: 04/24/2019) (1) |
Apr 23, 2019 | 194 | Joint MOTION to Adjust Case Management Plan (Responsive Expert Reports Deadline), filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 04/23/2019) (0) |
Apr 11, 2019 | 193 | ORDER granting 150 Motion to Compel Deposition Testimony - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 4/11/2019. (JRB) (Entered: 04/11/2019) (8) |
Apr 8, 2019 | 192 | MINUTE ORDER for proceedings held before Magistrate Judge Matthew P. Brookman: Discovery Conference held on 4/8/2019. Parties were represented by counsel. No further orders are entered at this time. Signed by Magistrate Judge Matthew P. Brookman. (TMB) (Entered: 04/08/2019) (1) |
Apr 4, 2019 | 190 | SCHEDULING ORDER: Telephonic Discovery Conference set for 4/8/2019 at 03:30 PM (Eastern Time) before Magistrate Judge Matthew P. Brookman. The purpose of this conference is to assist the parties in a discovery dispute. Before 5:00 p.m. (Eastern) on April 5, 2019, the parties are DIRECTED to e-mail the Magistrate Judge, at Lauren_Steed@insd.uscourts.gov, and opposing counsel, a brief outline, which shall not exceed two pages, of the dispute and their respective positions on the issue. Parties shall also e-mail copies of ONLY the discovery requests that are disputed, NOT ALL of the interrogatories, requests for production, and non-party subpoenas. Signed by Magistrate Judge Matthew P. Brookman on 4/4/2019.(TMB) (Entered: 04/04/2019) (2) |
Mar 26, 2019 | 189 | NOTICE OF SUPPLEMENTAL AUTHORITY, filed by Defendant APOTEX, INC., re 163 SEALED Document (Case Participants - doc), 162 Findings of Fact & Conclusions of Law (proposed). (Attachments: # 1 Exhibit A - Markman Opinion) (Zweig, Sally) (Entered: 03/26/2019) (0) |
Feb 19, 2019 | 188 | ORDER granting 184 Motion to Maintain Documents 151 and 160 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 2/19/2019. (JRB) (Entered: 02/19/2019) (3) |
Feb 7, 2019 | 184 | Unopposed MOTION to Maintain Document Under Seal 160 SEALED Response to Motion, 151 SEALED Document (Case Participants - doc) APOTEXS RENEWED UNOPPOSED MOTION TO FILE AND MAINTAIN UNDER SEAL EXHIBITS 6 & 7 TO APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY AND EXHIBITS 1 & 2 TO LILLYS OPPOSITION TO APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 02/07/2019) (0) |
Feb 7, 2019 | 185 | BRIEF/MEMORANDUM in Support re 184 Unopposed MOTION to Maintain Document Under Seal 160 SEALED Response to Motion, 151 SEALED Document (Case Participants - doc) APOTEXS RENEWED UNOPPOSED MOTION TO FILE AND MAINTAIN UNDER SEAL EXHIBITS 6 & 7 TO APOTEXS MOTION TO COMPEL DEPOSI , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 02/07/2019) (8) |
Feb 7, 2019 | 186 | REDACTION to 151 SEALED Document (Case Participants - doc) Exhibit 6 to Apotexs Motion to Compel Deposition Testimony (Dkt. 151) by APOTEX, INC.. (Zweig, Sally) (Entered: 02/07/2019) (30) |
Feb 7, 2019 | 187 | REDACTION to 160 SEALED Response to Motion Exhibit 2 to Lillys Opposition to Apotexs Motion to Compel Deposition Testimony (Dkt. 160) by APOTEX, INC.. (Zweig, Sally) (Entered: 02/07/2019) (29) |
Feb 4, 2019 | 182 | ORDER - Plaintiff Eli Lilly and Company ("Lilly"), by counsel, having filed a Renewed Unopposed Motion to File Under Seal and Maintain Under Seal Exhibits 8, 10 and 11 to Defendant Apotex Inc.'s Motion to Compel Deposition Testimony and Reply in Support of its Motion to Compel Deposition Testimony 180 , and the Court having considered the Motion, now finds that it should be GRANTED. Defendant's Motion to File and Provisionally Maintain Under Seal Page 10 to Reply in Support of Apotex's Motion to Compel Deposition Testimony 171 is DENIED AS MOOT. SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 2/4/2019. (JRB) Modified text on 2/5/2019 (TMB). (Entered: 02/04/2019) (2) |
Feb 4, 2019 | 183 | ORDER granting 178 Motion to Appear pro hac vice. Attorney Michael Xun Liu for ELI LILLY AND COMPANY,Michael Xun Liu for ELI LILLY AND COMPANY added. Copy sent to counsel via US Mail. Signed by Magistrate Judge Matthew P. Brookman on 2/4/2019. (JRB) (Entered: 02/04/2019) (2) |
Jan 31, 2019 | 178 | MOTION for Attorney(s) Michael Xun Liu to Appear pro hac vice (Filing fee $100, receipt number 0756-5263501), filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit A - Certification of Michael Xun Liu, # 2 Text of Proposed Order Granting Motion to Appear Pro Hac Vice)(Pollack-Milgate, Deborah) (Entered: 01/31/2019) (0) |
Jan 31, 2019 | 179 | REDACTION to 151 SEALED Document (Case Participants - doc) (151-6, 151-7, and 151-8) by ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit 1 - Proposed Redactions to ECF 151-6 (Ex. 8 ALIMTA Use Code Submissions), # 2 Exhibit 2 - Proposed Redactions to ECF 151-7 (Ex. 10 Pemetrexed Use Code Submissions), # 3 Exhibit 3 - Proposed Redactions to ECF 151-8 (Ex. 11 Pemetrexed Disodium Use Code Submissions))(Lemens, Andrew) (Entered: 01/31/2019) (0) |
Jan 31, 2019 | 180 | Unopposed MOTION to Maintain Document Under Seal 179 Redacted Document, 155 MOTION to Maintain Document Under Seal 151 SEALED Document (Case Participants - doc) APOTEXS MOTION TO FILE AND PROVISIONALLY MAINTAIN UNDER SEAL EXHIBITS 8, 10, AND 11 TO APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY, 171 MOTION to Maintain Document Under Seal 167 SEALED Document (Case Participants - doc) Apotex's Motion to File and Provisionally Maintain Under Seal Page 10 to Reply in Support of Motion to Compel Deposition Testimony, 177 Order on Motion to Seal/Maintain Under Seal Document, 167 SEALED Document (Case Participants - doc), 151 SEALED Document (Case Participants - doc) , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 01/31/2019) (0) |
Jan 31, 2019 | 181 | BRIEF/MEMORANDUM in Support re 180 Unopposed MOTION to Maintain Document Under Seal 179 Redacted Document, 155 MOTION to Maintain Document Under Seal 151 SEALED Document (Case Participants - doc) APOTEXS MOTION TO FILE AND PROVISIONALLY MAINTAIN UNDER SEAL EXHIBITS 8, , filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 01/31/2019) (5) |
Jan 22, 2019 | 177 | ORDER - In sum, 141 , 143 , 164 , and 169 are GRANTED. 153 and 161 are GRANTED in part and DENIED in part with leave to refile. 155 is DENIED with leave to refile. The Clerk of the Court is DIRECTED to unseal documents pursuant to this entry's directions. SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 1/22/2019. (JRB) (Entered: 01/22/2019) (7) |
Jan 18, 2019 | 176 | MINUTE ORDER for proceedings held before Magistrate Judge Matthew P. Brookman: Discovery Conference held on 1/18/2019. Parties were represented by counsel. No further orders are entered at this time. Signed by Magistrate Judge Matthew P. Brookman. (TMB) (Entered: 01/18/2019) (1) |
Jan 17, 2019 | 174 | BRIEF/MEMORANDUM in Support re 161 MOTION to Maintain Document Under Seal 160 SEALED Response to Motion to Compel Deposition Testimony APOTEXS BRIEF IN SUPPORT OF PLAINTIFFS MOTION TO FILE AND MAINTAIN UNDER SEAL PLAINTIFFS RESPONSE IN OPPOSITION TO APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY AND EXHIBITS 1-3, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 01/17/2019) (5) |
Jan 17, 2019 | 175 | REDACTION to 160 SEALED Response to Motion PLAINTIFF ELI LILLY AND COMPANYS RESPONSE IN OPPOSITION TO DEFENDANT APOTEX INC.S 150 MOTION TO COMPEL DEPOSITION TESTIMONY and Exhibit 3 Thereto by APOTEX, INC.. (Attachments: # 1 Exhibit REDACTED - Ex. 3 Chabner Deposition Excerpts)(Zweig, Sally) Modified on 1/18/2019 to add link to related motion (MAT). (Entered: 01/17/2019) (0) |
Jan 14, 2019 | 172 | SCHEDULING ORDER: Discovery Conference set for 1/18/2019 09:30 AM (Eastern Time) in Telephonic before Magistrate Judge Matthew P. Brookman. The information needed by counsel to participate in this telephonic conference will be provided by a separate notification. SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 1/14/2019.(JRB) (Entered: 01/14/2019) (2) |
Jan 11, 2019 | 167 | SEALED , re 150 Motion to Compel, filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Reply in Support of Apotex's Motion to Compel Deposition Testimony)(Zweig, Sally) (Entered: 01/11/2019) (0) |
Jan 11, 2019 | 168 | REDACTION to 167 SEALED Document (Case Participants - doc) Apotex's Reply in Support of Motion to Compel Deposition Testimony by APOTEX, INC.. (Zweig, Sally) (Entered: 01/11/2019) (20) |
Jan 11, 2019 | 169 | Unopposed MOTION to Maintain Document Under Seal 167 SEALED Document (Case Participants - doc) Apotex's Reply in Support of Motion to Compel Deposition Testimony, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 01/11/2019) (0) |
Jan 11, 2019 | 170 | BRIEF/MEMORANDUM in Support re 169 Unopposed MOTION to Maintain Document Under Seal 167 SEALED Document (Case Participants - doc) Apotex's Reply in Support of Motion to Compel Deposition Testimony , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 01/11/2019) (5) |
Jan 11, 2019 | 171 | MOTION to Maintain Document Under Seal 167 SEALED Document (Case Participants - doc) Apotex's Motion to File and Provisionally Maintain Under Seal Page 10 to Reply in Support of Motion to Compel Deposition Testimony, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 01/11/2019) (0) |
Jan 8, 2019 | 162 | Findings of Fact & Conclusions of Law (proposed) Regarding Claim Construction by ELI LILLY AND COMPANY. (Perlman, Adam) (Entered: 01/08/2019) (26) |
Jan 8, 2019 | 163 | SEALED Proposed Findings of Facts and Conclusions of Law, filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Proposed Findings of Facts and Conclusions of Law)(Zweig, Sally) (Entered: 01/08/2019) (0) |
Jan 8, 2019 | 164 | Unopposed MOTION to Maintain Document Under Seal 163 SEALED Document (Case Participants - doc) SEALED Proposed Findings of Fact and Conclusions of Law, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 01/08/2019) (0) |
Jan 8, 2019 | 165 | BRIEF/MEMORANDUM in Support re 164 Unopposed MOTION to Maintain Document Under Seal 163 SEALED Document (Case Participants - doc) SEALED Proposed Findings of Fact and Conclusions of Law , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 01/08/2019) (5) |
Jan 8, 2019 | 166 | REDACTION to 163 SEALED Document (Case Participants - doc) REDACTED Proposed Findings of Facts and Conclusions of Law by APOTEX, INC.. (Zweig, Sally) (Entered: 01/08/2019) (30) |
Jan 4, 2019 | 160 | SEALED RESPONSE re 150 MOTION to Compel Deposition Testimony , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit 1 - Apotex Ltr. to FDA, # 2 Exhibit 2 - Krishnan Deposition Excerpts, # 3 Exhibit 3 - Chabner Deposition Excerpts)(Lemens, Andrew) (Entered: 01/04/2019) (0) |
Jan 4, 2019 | 161 | MOTION to Maintain Document Under Seal 160 SEALED Response to Motion to Compel Deposition Testimony, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 01/04/2019) (0) |
Dec 27, 2018 | 159 | ORDER granting 158 Motion for Extension of Time to File Response to 150 MOTION to Compel Deposition Testimony to 1/4/19. Signed by Magistrate Judge Matthew P. Brookman on 12/27/2018. (JRB) (Entered: 12/27/2018) (1) |
Dec 21, 2018 | 158 | Unopposed MOTION for Extension of Time to File Response to 01/04/2019 re 150 MOTION to Compel Deposition Testimony , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 12/21/2018) (0) |
Dec 18, 2018 | 157 | ORDER - granting 156 Joint Motion to Adjust Case Management Plan. (See Order for deadlines.) Signed by Judge Tanya Walton Pratt on 12/18/2018.(NAD) (Entered: 12/18/2018) (2) |
Dec 17, 2018 | 150 | MOTION to Compel Deposition Testimony, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/17/2018) (0) |
Dec 17, 2018 | 151 | SEALED Brief in Support of Motion to Compel Deposition Testimony, re 150 Motion to Compel, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit 1- SEALED Notice of Deposition of Lilly, # 2 Exhibit 5-SEALED Notice of Deposition of Apotex, # 3 Exhibit 6-SEALED Krishnan Deposition, # 4 Exhibit 7 (Part 1) -SEALED Krishnan DX-3, # 5 Exhibit 7 (Part 2) -SEALED Krishnan DX-3, # 6 Exhibit 8- SEALED ALIMTA Use Code Submissions, # 7 Exhibit 10- SEALED Pemetrexed Use Code Submissions, # 8 Exhibit 11-SEALED Pemetrexed Disodium Use Code Submission, # 9 Exhibit 13-SEALED Apotex Letter to the Court (Nov 14, 2018), # 10 Exhibit 17-SEALED Chabner Report, # 11 Exhibit 8-SEALED Buckton Report)(Zweig, Sally) (Entered: 12/17/2018) (0) |
Dec 17, 2018 | 152 | REDACTION to 151 SEALED Document (Case Participants - doc) Brief in Support of Motion to Compel Testimony by APOTEX, INC.. (Attachments: # 1 Exhibit 1-REDACTED Notice of Deposition of Lilly, # 2 Exhibit 2- 2009 Label, # 3 Exhibit 3- 2004 Label, # 4 Exhibit 4- Lilly Patent List, # 5 Exhibit 5- REDACTED Notice of Deposition of Apotex, # 6 Exhibit 6- Krishnan Depo., # 7 Exhibit 7- Krishnan DX-3, # 8 Exhibit 8-ALIMTA Use Code Submissions, # 9 Exhibit 9-Lilly 974 Patent, # 10 Exhibit 10-Pemetrexed Use Code Submissions, # 11 Exhibit 11-Pemetrexed Disodium Use Code Submissions, # 12 Exhibit 12-Lilly 209 Patent, # 13 Exhibit 13-Apotex Letter to the Court dated November 14, 2018, # 14 Exhibit 14-Lilly Appeal Brief, # 15 Exhibit 15-Thurston Report, # 16 Exhibit 16-Ferry Report, # 17 Exhibit 17- REDACTED Chabner Report, # 18 Exhibit 18- REDACTED Buckton Report, # 19 Exhibit 19- What is ALIMTA?, # 20 Exhibit 20-Knauf (S.D. Ind. 2018))(Zweig, Sally) (Entered: 12/17/2018) (0) |
Dec 17, 2018 | 153 | MOTION to Maintain Document Under Seal 151 SEALED Document (Case Participants - doc) APOTEXS MOTION TO FILE AND MAINTAIN BRIEF IN SUPPORT OF APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY AND EXHIBITS 1, 5-7, 13, 17, AND 18 THERETO UNDER SEAL, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/17/2018) (0) |
Dec 17, 2018 | 154 | BRIEF/MEMORANDUM in Support re 153 MOTION to Maintain Document Under Seal 151 SEALED Document (Case Participants - doc) APOTEXS MOTION TO FILE AND MAINTAIN BRIEF IN SUPPORT OF APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY AND EXHIBITS 1, 5-7, 13, 17, AND 18 THERETO UNDER SEAL< , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 12/17/2018) (6) |
Dec 17, 2018 | 155 | MOTION to Maintain Document Under Seal 151 SEALED Document (Case Participants - doc) APOTEXS MOTION TO FILE AND PROVISIONALLY MAINTAIN UNDER SEAL EXHIBITS 8, 10, AND 11 TO APOTEXS MOTION TO COMPEL DEPOSITION TESTIMONY, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/17/2018) (0) |
Dec 17, 2018 | 156 | Joint MOTION to Amend/Correct 147 Order on Motion for Reconsideration, 32 Order: Case ManagementSet Deadlines/Hearings, 127 Order on Motion to Amend/Correct, 107 Order on Motion to Amend/CorrectScheduling , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 12/17/2018) (0) |
Nov 30, 2018 | 148 | BRIEF/MEMORANDUM in Support re 141 MOTION to Maintain Document Under Seal 140 SEALED Document (Case Participants - doc) Infringement Contentions APOTEXS BRIEF IN SUPPORT OF PLAINTIFFS MOTION TO FILE AND MAINTAIN UNDER SEAL PLAINTIFFS INFRINGEMENT CONTENTIONS, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 11/30/2018) (5) |
Nov 30, 2018 | 149 | REDACTION to 140 SEALED Document (Case Participants - doc) PLAINTIFF ELI LILLY AND COMPANYS INFRINGEMENT CONTENTIONS by APOTEX, INC.. (Zweig, Sally) (Entered: 11/30/2018) (27) |
Nov 29, 2018 | 147 | ENTRY ON APOTEX'S 132 MOTION FOR RECONSIDERATION - In light of the misapprehension and Lilly's lack of objection to correcting any misapprehension, the Court GRANTS Apotex's Motion for Reconsideration (Filing No. 132 ). The Entry Vacating Markman Hearing (Filing No. 130 ) is amended to reflect that the parties are not in agreement that the DRL and Hospira decisions resolved the claim construction issues in this case. The Court interprets the parties' positions as indicating that an actual Markman hearing is unnecessary. However, because the parties do not agree on the applicability of the DRL and Hospira decisions, the Court further amends the Entry Vacating Markman Hearing to ORDER the parties to submit separate proposed findings of fact and conclusions of law for all the disputed claim terms and phrases rather than to submit a joint proposed claim construction order within thirty (30) days of the date of this Entry. Thereafter, the Court will promptly issue an Order. (See Entry.) Signed by Judge Tanya Walton Pratt on 11/29/2018. (NAD) (Entered: 11/30/2018) (4) |
Nov 19, 2018 | 146 | MINUTE ORDER for proceedings held before Magistrate Judge Matthew P. Brookman: Discovery Conference held on 11/15/2018. Parties were represented by counsel. No further orders are entered at this time. Signed by Magistrate Judge Matthew P. Brookman. (TMB) (Entered: 11/19/2018) (1) |
Nov 16, 2018 | 140 | SEALED Infringement Contentions, filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 11/16/2018) (0) |
Nov 16, 2018 | 141 | MOTION to Maintain Document Under Seal 140 SEALED Document (Case Participants - doc) Infringement Contentions, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 11/16/2018) (0) |
Nov 16, 2018 | 142 | SEALED Invalidity Contentions, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit SEALED Invalidity Contentions)(Zweig, Sally) (Entered: 11/16/2018) (0) |
Nov 16, 2018 | 143 | Unopposed MOTION to Maintain Document Under Seal 142 SEALED Document (Case Participants - doc) Apotex's Invalidity Contentions, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 11/16/2018) (0) |
Nov 16, 2018 | 144 | BRIEF/MEMORANDUM in Support re 143 Unopposed MOTION to Maintain Document Under Seal 142 SEALED Document (Case Participants - doc) Apotex's Invalidity Contentions , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 11/16/2018) (5) |
Nov 16, 2018 | 145 | REDACTION to 142 SEALED Document (Case Participants - doc) REDACTED Apotex's Invalidity Contentions by APOTEX, INC.. (Zweig, Sally) (Entered: 11/16/2018) (16) |
Nov 13, 2018 | 138 | SCHEDULING ORDER: Discovery Conference set for 11/15/2018 AT 09:30 AM (Eastern Time) in Telephonic before Magistrate Judge Matthew P. Brookman. The purpose of this conference is to assist the parties in a discovery dispute. ***SEE ORDER*** Signed by Magistrate Judge Matthew P. Brookman on 11/13/2018.(TMB) (Entered: 11/13/2018) (1) |
Nov 7, 2018 | 137 | ORDER granting 131 Motion for Extension of Time to Serve Responses to Apotex's First Set of Interrogatories - Any responses to Apotex's First Set of Interrogatories (Nos. 1-25) that were served on or before November 2, 2018, are to be deemed timely. Signed by Magistrate Judge Matthew P. Brookman on 11/7/2018. (JRB) (Entered: 11/07/2018) (2) |
Oct 30, 2018 | 136 | REPLY in Support of Motion re 132 MOTION for Reconsideration re 130 Scheduling Order [APOTEX'S MOTION FOR RECONSIDERATION OF THE ENTRY VACATING MARKMAN HEARING] , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/30/2018) (8) |
Oct 26, 2018 | 135 | RESPONSE in Opposition re 132 MOTION for Reconsideration re 130 Scheduling Order [APOTEX'S MOTION FOR RECONSIDERATION OF THE ENTRY VACATING MARKMAN HEARING] , filed by Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 10/26/2018) (8) |
Oct 19, 2018 | 134 | RESPONSE in Opposition re 131 MOTION for Extension of Time to 11/02/2018 to Serve Responses to Apotex's First Set of Interrogatories , filed by Counter Claimant APOTEX, INC., Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/19/2018) (4) |
Oct 18, 2018 | 132 | MOTION for Reconsideration re 130 Scheduling Order [APOTEX'S MOTION FOR RECONSIDERATION OF THE ENTRY VACATING MARKMAN HEARING], filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A - Apotex's Proposed Amended Entry Vacating Markman Hearing, # 2 Exhibit B - Lilly's Original Proposed Order, # 3 Exhibit C - Lilly's Revised Proposed Order)(Zweig, Sally) (Entered: 10/18/2018) (0) |
Oct 18, 2018 | 133 | NOTICE Regarding Proposed Entries on Claim Construction, filed by Plaintiff ELI LILLY AND COMPANY, re 130 Scheduling Order. (Attachments: # 1 Appendix 1 - Lilly's Proposed Entry, # 2 Appendix 2 - Apotex's Proposed Entry) (Lemens, Andrew) (Entered: 10/18/2018) (0) |
Oct 17, 2018 | 131 | MOTION for Extension of Time to 11/02/2018 to Serve Responses to Apotex's First Set of Interrogatories, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A - Correspondence)(Lemens, Andrew) (Entered: 10/17/2018) (0) |
Oct 11, 2018 | 130 | ENTRY VACATING MARKMAN HEARING - It appears that the parties are in agreement that the claim construction issues in this case have been resolved by the Court's decisions in other cases and that a Markman hearing is not necessary. The Court accepts the parties' position. Therefore, the Markman hearing currently scheduled for October 25, 2018, is VACATED, and the parties are ORDERED to submit a joint proposed claim construction order within seven (7) days of the date of this Entry. (See Entry.) Signed by Judge Tanya Walton Pratt on 10/11/2018.(NAD) (Entered: 10/11/2018) (2) |
Oct 1, 2018 | 129 | REPLY in Support of Motion re 123 MOTION to Set Teleconference , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 10/01/2018) (20) |
Sep 26, 2018 | 128 | RESPONSE to Apotex Inc.'s Motion to Set Teleconference, re 125 Order on Motion, filed by Plaintiff ELI LILLY AND COMPANY. (Perlman, Adam) (Entered: 09/26/2018) (11) |
Sep 21, 2018 | 127 | ORDER - granting 126 Joint Motion to Adjust Case Management Plan. (See Order for deadlines). Signed by Judge Tanya Walton Pratt on 9/21/2018. (NAD) (Entered: 09/24/2018) (2) |
Sep 20, 2018 | 126 | Joint MOTION to Amend/Correct 32 Order: Case ManagementSet Deadlines/Hearings, 107 Order on Motion to Amend/CorrectScheduling , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 09/20/2018) (0) |
Sep 14, 2018 | 125 | ENTRY - This matter is before the Court on Defendant Apotex's Motion to Set Teleconference (Dkt. 123 ) filed September 12, 2018. In that Motion, Apotex requests a teleconference to discuss three possible approaches to expedite a decision on the pending claim construction issues. To the extent the motion requests a telephonic conference, that request is DENIED. The Court believes a more efficient procedure is to allow Plaintiff Eli Lilly and Company to respond to the three main points and approaches in writing. The Court is not opposed to adopting some of the suggested alternatives in Apotex Motion. Eli Lilly and Company shall file its response no later than September 26, 2018. Thereafter, the Court will promptly issue an order on how it wishes to proceed. Signed by Judge Tanya Walton Pratt on 9/14/2018. (NAD) (Entered: 09/14/2018) (2) |
Sep 12, 2018 | 123 | MOTION to Set Teleconference, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 09/12/2018) (0) |
Sep 12, 2018 | 124 | BRIEF/MEMORANDUM in Support re 123 MOTION to Set Teleconference , filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit 1-Hospira Appeal Brief)(Zweig, Sally) (Entered: 09/12/2018) (0) |
Aug 29, 2018 | 122 | MINUTE ORDER for proceedings held before Magistrate Judge Matthew P. Brookman: Discovery Conference held on 8/28/2018. Parties were represented by counsel. No further orders are entered at this time. Signed by Magistrate Judge Matthew P. Brookman. (TMB) (Entered: 08/29/2018) (1) |
Aug 28, 2018 | 121 | SCHEDULING ORDER - Due to congestion of the Court's calendar, the Markman hearing scheduled September 17, 2018 is RESCHEDULED to commence on October 25, 2018 at 9:00 a.m. in Courtroom 344, Birch Bayh Federal Building and U.S. Courthouse, Indianapolis, Indiana. Signed by Judge Tanya Walton Pratt on 8/28/2018.(NAD) (Entered: 08/29/2018) (2) |
Aug 23, 2018 | 120 | ORDER granting 117 Motion to Maintain Documents Under Seal 114 SEALED Document (Case Participants - doc) and 113 SEALED Document (Case Participants - doc). Signed by Magistrate Judge Matthew P. Brookman on 8/23/2018. (JRB) (Entered: 08/23/2018) (2) |
Aug 17, 2018 | 112 | RESPONSE to Claim Construction Brief, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit 17 - Letter re Claim Construction)(Perlman, Adam) (Entered: 08/17/2018) (0) |
Aug 17, 2018 | 113 | SEALED Responsive Markman Brief, re 86 Initial Markman/Claim Construction Brief, filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Responsive Markman Brief)(Zweig, Sally) (Entered: 08/17/2018) (0) |
Aug 17, 2018 | 114 | SEALED Supplemental Appendix, re 113 SEALED Document (Case Participants - doc), filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix SEALED Supplemental Appendix to Responsive Markman Brief, # 2 Exhibit SEALED Chabner Deposition Transcript (June 2018) (CC_1509-51), # 3 Exhibit SEALED Chabner Deposition Ex. 1 (CC_1552-91), # 4 Exhibit SEALED Chabner Deposition Ex. 14 (CC_1619), # 5 Exhibit SEALED Chabner Deposition Ex. 36 (CC_2030), # 6 Exhibit SEALED Chabner Deposition Ex. 38 (CC_2032), # 7 Exhibit SEALED Chabner Deposition Ex. 40 (CC_2047), # 8 Exhibit SEALED Chabner Deposition Ex. 41 (CC_2048), # 9 Exhibit SEALED Chabner Deposition Ex. 42 (CC_2049-56), # 10 Exhibit SEALED Ratain Deposition Transcript (May 2018) (CC_2082-98), # 11 Exhibit SEALED Buckton Deposition Transcript (June 2018) (CC_2099-134))(Zweig, Sally) Modified on 8/20/2018 - Edited text to match title (NAD). (Entered: 08/17/2018) (0) |
Aug 17, 2018 | 115 | REDACTED DOCUMENT Redacted Responsive Markman Brief and Exhbits, re 113 SEALED Document (Case Participants - doc), 114 SEALED Document (Case Participants - doc), filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix REDACTED Supplemental Appendix to Responsive Markman Brief, # 2 Exhibit REDACTED Chabner Deposition Transcript (June 2018) (CC_1509-51), # 3 Exhibit REDACTED Chabner Deposition Ex. 1 (CC_1552-91), # 4 Exhibit Chabner Deposition Ex. 2 (CC_1592), # 5 Exhibit Chabner Deposition Ex. 3 (CC_1593-96), # 6 Exhibit Chabner Deposition Ex. 4 (CC_1597), # 7 Exhibit Chabner Deposition Ex. 5 (CC_1598), # 8 Exhibit Chabner Deposition Ex. 6 (CC_1599), # 9 Exhibit Chabner Deposition Ex. 7 (CC_1600), # 10 Exhibit Chabner Deposition Ex. 8 (CC_1601-08), # 11 Exhibit Chabner Deposition Ex. 9 (CC_1609), # 12 Exhibit Chabner Deposition Ex. 10 (CC_1610), # 13 Exhibit Chabner Deposition Ex. 11 (CC_1611), # 14 Exhibit Chabner Deposition Ex. 12 (CC_1612-17), # 15 Exhibit Chabner Deposition Ex. 13 (CC_1618), # 16 Exhibit FILED UNDER SEAL SEALED Chabner Deposition Ex. 14 (CC_1619), # 17 Exhibit Chabner Deposition Ex. 15 (CC_1620-41), # 18 Exhibit Chabner Deposition Ex. 16 (CC_1642-47), # 19 Exhibit Chabner Deposition Ex. 17 (CC_1648-61), # 20 Exhibit Chabner Deposition Ex. 18 (CC_1662-71), # 21 Exhibit Chabner Deposition Ex. 19 (CC_1672)Chabner Deposition Ex. 19 (CC_1672), # 22 Exhibit Chabner Deposition Ex. 20 (CC_1673-78), # 23 Exhibit Chabner Deposition Ex. 21 (CC_1679-90), # 24 Exhibit Chabner Deposition Ex. 22 (CC_1691-98), # 25 Exhibit Chabner Deposition Ex. 23 (CC_1699-710), # 26 Exhibit Chabner Deposition Ex. 24 (CC_1711-16), # 27 Exhibit Chabner Deposition Ex. 25 (CC_1717-26), # 28 Exhibit Chabner Deposition Ex. 26 (CC_1727-68), # 29 Exhibit Chabner Deposition Ex. 27 (CC_1769-802), # 30 Exhibit Chabner Deposition Ex. 28 (CC_1803-30), # 31 Exhibit Chabner Deposition Ex. 29 (CC_1831-24) (Part 1 of 2), # 32 Exhibit Chabner Deposition Ex. 29 (CC_1831-24) (Part 2 of 2), # 33 Exhibit Chabner Deposition Ex. 30 (CC_1925-2012), # 34 Exhibit Chabner Deposition Ex. 31 (CC_2013-20), # 35 Exhibit Chabner Deposition Ex. 32 (CC_2021-26), # 36 Exhibit Chabner Deposition Ex. 33 (CC_2027), # 37 Exhibit Chabner Deposition Ex. 34 (CC_2028), # 38 Exhibit Chabner Deposition Ex. 35 (CC_2029), # 39 Exhibit FILED UNDER SEAL Chabner Deposition Ex. 36 (CC_2030), # 40 Exhibit Chabner Deposition Ex. 37 (CC_2031), # 41 Exhibit FILED UNDER SEAL Chabner Deposition Ex. 38 (CC_2032), # 42 Exhibit Chabner Deposition Ex. 39 (CC_2033-46), # 43 Exhibit FILED UNDER SEAL Chabner Deposition Ex. 40 (CC_2047), # 44 Exhibit FILED UNDER SEAL Chabner Deposition Ex. 41 (CC_2048), # 45 Exhibit FILED UNDER SEAL Chabner Deposition Ex. 42 (CC_2049-56), # 46 Exhibit Chabner Deposition Ex. 43 (CC_2057-58), # 47 Exhibit Chabner Deposition Ex. 44 (CC_2059-68), # 48 Exhibit Chabner Deposition Ex. 45 (CC_2069-80), # 49 Exhibit Chabner Deposition Ex. 46 (CC_2081), # 50 Exhibit REDACTED Ratain Deposition Transcript (May 2018) (CC_2082-98), # 51 Exhibit REDACTED Buckton Deposition Transcript (June 2018) (CC_2099-134), # 52 Exhibit Excerpt of Lillys Discovery Responses (May 2018) (CC_2135-43), # 53 Exhibit Excerpt of Lillys Discovery Responses (July 2018) (CC_2144-51), # 54 Exhibit Excerpt of Pinal Report dated 3/21/17 (Lilly v. Dr. Reddys) (CC_2152-58), # 55 Exhibit Excerpt of Trial Transcript dated 2/1/18 (Lilly v. Dr. Reddys) (CC_ 2159-65), # 56 Exhibit Excerpt of Lilly Brief dated 8/31/17 (Lilly v. Dr. Reddys) (CC_2166-67), # 57 Exhibit Excerpt of Lilly Post-Trial Brief dated 6/19/15 (Lilly v. Teva) (CC_2168-75), # 58 Exhibit Excerpt of Lilly Post-Trial Reply dated 7/22/15 (Lilly v. Teva) (CC_2176-79), # 59 Exhibit UK Trial Court Decision dated 5/15/14 (Actavis v. Lilly) (CC_2180-271), # 60 Exhibit UK Appellate Court Decision dated 6/25/15 (Actavis v. Lilly) (CC_2272-311), # 61 Exhibit UK Supreme Court Decision dated 7/12/17 (Actavis v. Lilly) (CC_2312-50), # 62 Exhibit Calvert Publication dated 1998 (CC_2351-56), # 63 Exhibit Calvert Publication dated 1999 (CC_2357-64), # 64 Exhibit Taylor Publication dated 2011 (CC_2365-72), # 65 Exhibit National Cancer Institute Definition (CC_2373-74), # 66 Exhibit Lumen Introduction to Chemistry (CC_2375-78), # 67 Exhibit Excerpt of Orange Book 2011 (CC_2379-82), # 68 Exhibit Excerpt of Orange Book 2013 (CC_2383-85), # 69 Exhibit Excerpt of Orange Book Patent Use Codes (CC_2386-89), # 70 Exhibit NIH Lometrexol dated 12/13/16 (CC_2390-91))(Zweig, Sally) Modified on 8/20/2018 - Corrected event(NAD). (Entered: 08/17/2018) (0) |
Aug 17, 2018 | 116 | REDACTION to 113 SEALED Document (Case Participants - doc) Redacted Responsive Markman Brief by APOTEX, INC.. (Zweig, Sally) (Entered: 08/17/2018) (30) |
Aug 17, 2018 | 117 | Unopposed MOTION to Maintain Document Under Seal 114 SEALED Document (Case Participants - doc), 113 SEALED Document (Case Participants - doc) Apotexs Responsive Markman Brief; the Supplemental Appendix to Apotexs Responsive Markman Brief; the Chabner Claim Construction Deposition Transcript (CC_1509-51) and Exhibits 1, 14, 36, 38, 40-42 (CC_1552-91, 1619, 2030, 2032, 2047-56); the Ratain Claim Construction Deposition Transcript (CC_2082-98); and the Buckton Claim Construction Deposition Transcript (CC_2099-134), filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 08/17/2018) (0) |
Aug 17, 2018 | 118 | BRIEF/MEMORANDUM in Support re 117 Unopposed MOTION to Maintain Document Under Seal 114 SEALED Document (Case Participants - doc), 113 SEALED Document (Case Participants - doc) Apotexs Responsive Markman Brief; the Supplemental Appendix to Apotexs Responsive Markman Brief; t , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 08/17/2018) (6) |
Aug 15, 2018 | 111 | SCHEDULING ORDER: Telephonic Discovery Conference set for 8/28/2018 at 03:00 PM (Eastern Time) before Magistrate Judge Matthew P. Brookman. The information needed by counsel to participate in this telephonic conference will be provided by a separate notification. Signed by Magistrate Judge Matthew P. Brookman on 8/15/2018.(JRB) Modified on 8/15/2018 (JRB). (Entered: 08/15/2018) (1) |
Jul 27, 2018 | 109 | ORDER granting 105 Motion to Maintain Document Under Seal - IT IS THEREFORE ORDERED that the Court shall maintain Lilly's Opening Claim Construction Brief and Exhibits 2-7 and 12 (Dkt. Nos. 88, 88-2, 88-3, 88-4, 88-5, 88-6, 88-7, 88-12) under seal. A redacted public version of the documents (Lilly's Opening Claim Construction Brief and Exhibits 2-7) shall be available on the docket. (Dkt. Nos. 104, 104-1, 104-2, 104-3, 104- 4, 104-5, 104-6). IT IS FURTHER ORDERED that the Court shall unseal Exhibits 1, 8-11, and 13-16 to Lilly's Opening Claim Construction Brief (Dkt. Nos. 88-1, 88-8, 88-9, 88-10, 88-11, 88-13, 88-14, 88-15, 88-16). Signed by Magistrate Judge Matthew P. Brookman on 7/27/2018. (JRB) (Entered: 07/27/2018) (1) |
Jul 27, 2018 | 110 | ORDER - granting 108 Motion to Withdraw Attorney Appearance. Attorney Alec T. Swafford withdrawn. Signed by Judge Tanya Walton Pratt on 7/27/2018. (NAD) (Entered: 07/27/2018) (1) |
Jul 26, 2018 | 108 | MOTION to Withdraw Attorney Appearance of Alec T. Swafford, filed by Plaintiff ELI LILLY AND COMPANY, Counter Defendant ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Lemens, Andrew) (Entered: 07/26/2018) (0) |
Jul 24, 2018 | 104 | REDACTION to 88 SEALED Document (Case Participants - doc) Plaintiff's Opening Claim Construction Brief and Exhibits 2-7 thereto by APOTEX, INC.. (Attachments: # 1 Exhibit 2-REDACTED Declaration of Bruce A. Chabner, # 2 Exhibit 3- REDACTED Deposition of Bruce A. Chabner, # 3 Exhibit 4-REDACTED Claim Construction Expert Report of Mark J. Ratain, # 4 Exhibit 5-REDACTED Deposition of Mark Ratain, # 5 Exhibit 6-REDACTED Claim Construction Expert Report of Graham Buckton, # 6 Exhibit 7-REDACTED Deposition of Graham Buckton)(Zweig, Sally) (Entered: 07/24/2018) (0) |
Jul 24, 2018 | 105 | Unopposed MOTION to Maintain Document Under Seal 88 SEALED Document (Case Participants - doc) Plaintiff's Opening Claim Construction Brief and Exhibits 2-7 and 12 thereto, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 07/24/2018) (0) |
Jul 24, 2018 | 106 | BRIEF/MEMORANDUM in Support re 105 Unopposed MOTION to Maintain Document Under Seal 88 SEALED Document (Case Participants - doc) Plaintiff's Opening Claim Construction Brief and Exhibits 2-7 and 12 thereto , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 07/24/2018) (6) |
Jul 24, 2018 | 107 | ORDER granting Joint 103 Motion to Amend/Correct Case Management Plan Deadlines. Scheduling: Bench Trial reset for 1/13/2020 at 09:00 AM in room #344, United States Courthouse, 46 E. Ohio Street, Indianapolis, Indiana before Judge Tanya Walton Pratt., Final Pretrial Conference reset for 12/18/2019 at 10:00 AM in room #330, United States Courthouse, 46 E. Ohio Street, Indianapolis, Indiana before Judge Tanya Walton Pratt. Dispositive Motions due by 2/19/2019., Discovery due by 2/16/2019. (See Order for additional deadlines). Signed by Judge Tanya Walton Pratt on 7/24/2018.(MAC) (Entered: 07/25/2018) (2) |
Jul 20, 2018 | 103 | Joint MOTION to Amend/Correct 32 Order: Case ManagementSet Deadlines/Hearings, 75 Scheduling Order, 69 Scheduling Order, 78 Order on Motion , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 07/20/2018) (0) |
Jul 13, 2018 | 102 | ORDER denying 89 Motion to Maintain Document Under Seal - Pursuant to Local Rule 5-11(g), the Clerk is DIRECTED to unseal the document 21 days after this Entry, unless a renewed motion is filed to maintain the document under seal. SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 7/13/2018. (JRB) (Entered: 07/13/2018) (2) |
Jun 25, 2018 | 101 | ORDER granting 100 Motion to Maintain Documents Under Seal - Court shall maintain under seal the Ratain Claim Construction Report [90-1] and Buckton Claim Construction Report [92-1] in Appendix to Apotex's Opening Markman Brief. Redacted public versions of the Ratain Claim Construction Report (Dkt. 90-1) and Buckton Claim Construction Report (Dkt. 92-1) in Appendix to Apotex's Opening Markman Brief shall be available on the docket 98 and 99 . SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 6/25/2018. (JRB) (Entered: 06/25/2018) (1) |
Jun 21, 2018 | 97 | ORDER granting 95 Motion to Maintain Document 94 Under Seal - SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 6/21/2018. (JRB) (Entered: 06/21/2018) (1) |
Jun 21, 2018 | 98 | REDACTION to 90 Appendix of Exhibits in Support REDACTED Ratain Claim Construction Report (May 2018) (CC_1-88) [DE 90-1] by APOTEX, INC.. (Zweig, Sally) (Entered: 06/21/2018) (30) |
Jun 21, 2018 | 99 | REDACTION to 92 Appendix of Exhibits in Support REDACTED Buckton Claim Construction Report (May 2018) (CC_702-91) [DE 92-1] by APOTEX, INC.. (Zweig, Sally) (Entered: 06/21/2018) (30) |
Jun 21, 2018 | 100 | MOTION to Seal Document 92 Appendix of Exhibits in Support, 90 Appendix of Exhibits in Support REDACTED Ratain Claim Construction Report (May 2018) (CC_1-88) [DE 90-1] and REDACTED Buckton Claim Construction Report (May 2018) (CC_702-91) [DE 92-1], filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 06/21/2018) (0) |
Jun 19, 2018 | 86 | Initial Markman/Claim Construction Brief Apotex's Opening Markman Brief by APOTEX, INC.. (Zweig, Sally) (Entered: 06/19/2018) (30) |
Jun 19, 2018 | 87 | ***PLEASE DISREGARD - INCORRECT FILING***SEALED PLAINTIFF ELI LILLY AND COMPANYS OPENING CLAIM CONSTRUCTION BRIEF, filed by Plaintiff ELI LILLY AND COMPANY. (Perlman, Adam) Modified on 6/20/2018 (NAD). (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 88 | SEALED Eli Lilly and Companys Opening Claim Construction Brief, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit 1 U.S. Patent No. 7,772,209, # 2 Exhibit 2 Declaration of Bruce A. Chabner, # 3 Exhibit 3 Deposition of Bruce A. Chabner, # 4 Exhibit 4 Claim Construction Expert Report of Mark J. Ratain, # 5 Exhibit 5 Deposition of Mark Ratain, # 6 Exhibit 6 Claim Construction Expert Report of Graham Buckton, # 7 Exhibit 7 Deposition of Graham Buckton, # 8 Exhibit 8 ALIMTA FH Label, # 9 Exhibit 9 Calvert III, # 10 Exhibit 10 Rusthoven, # 11 Exhibit 11 Scagliotti, # 12 Exhibit 12 FDA Meeting Minutes, # 13 Exhibit 13 UKSC Decision, # 14 Exhibit 14 EWCA Decision, # 15 Exhibit 15 Apotexs IPR Petitions, # 16 Exhibit 16 Declaration of Mark Ratain)(Perlman, Adam) Modified on 7/27/2018 (JRB). (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 89 | MOTION to Maintain Document Under Seal 88 SEALED Document (Case Participants - doc), 87 SEALED Document (Case Participants - doc) Eli Lilly and Company's Opening Claim Construction Brief, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Perlman, Adam) (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 90 | Appendix of Exhibits in Support of Motion re 86 Initial Markman/Claim Construction Brief Apotex's Opening Markman Brief by APOTEX, INC. Part 1 - Ratain Claim Construction Report and Exs. 1-27, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit REDACTED Ratain Claim Construction Report (May 2018) (CC 1-88), # 2 Exhibit Ratain Ex. 1 - 209 Patent (CC 89-98), # 3 Exhibit Ratain Ex. 2 - 860 Application ( 209 PH) (CC 99-119), # 4 Exhibit Ratain Ex. 3 - Preliminary Amendment dated 7/11/07 ( 209 PH) (CC 120-26), # 5 Exhibit Ratain Ex. 4 - Second Preliminary Amendment dated 12/8/08 ( 209 PH) (CC 127-30), # 6 Exhibit Ratain Ex. 5 - Examiner Action dated 2/18/09 ( 209 PH) (CC 131-39), # 7 Exhibit Ratain Ex. 6 - Lilly Response dated 11/13/09 ( 209 PH) (CC 140-51), # 8 Exhibit Ratain Ex. 7 - Label 2009 ( 209 PH) (CC 152-74), # 9 Exhibit Ratain Ex. 8 - US Trademark Application dated 2/2/98 (CC 175-76), # 10 Exhibit Ratain Ex. 9 - EP Trademark Application dated 5/19/98 (CC 177-80), # 11 Exhibit Ratain Ex. 10 - 691 Application ( 365 Patent) (CC 181-94), # 12 Exhibit Ratain Ex. 11 - 310 Application ( 209 Patent) (CC 195-210), # 13 Exhibit Ratain Ex. 12 - 599 Application ( 365 Patent) (CC 211-26), # 14 Exhibit Ratain Ex. 13 - 859 Application ( 209 Patent) (CC 227-43), # 15 Exhibit Ratain Ex. 14 - 648 Application ( 365 Patent) (CC 244-57), # 16 Exhibit Ratain Ex. 15 - 486 Application ( 037 Publication) (CC 258-68), # 17 Exhibit Ratain Ex. 16 - 448 Application ( 209 Patent) (CC 269-88), # 18 Exhibit Ratain Ex. 17 - 233 Application ( 037 Publication) (CC 289-302), # 19 Exhibit Ratain Ex. 18 - 037 Publication (CC 303-13), # 20 Exhibit Ratain Ex. 19 - 379 Application ( 365 Patent) (CC 314-29), # 21 Exhibit Ratain Ex. 20 - Initial Claims dated 11/19/02 ( 065 PH) (CC 330-38), # 22 Exhibit Ratain Ex. 21 - Initial EPO Claims dated 1/8/03 (EP508 PH) (CC 339-46), # 23 Exhibit Ratain Ex. 22 - 083 Publication ( 365 Patent) (CC 347-50), # 24 Exhibit Ratain Ex. 23 - 365 Patent (CC 351-56), # 25 Exhibit Ratain Ex. 24 - Label 2004 (CC 357-70), # 26 Exhibit Ratain Ex. 25 - Examiner Action dated 3/9/04 (EP508 PH) (CC 371-76), # 27 Exhibit Ratain Ex. 26 - European Patent Convention, Article 84 (CC 377-78), # 28 Exhibit Ratain Ex. 27 - Examiner Action dated 9/27/04 ( 065 PH) (CC 379-89))(Zweig, Sally) Modified on 6/25/2018 (JRB). (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 91 | Appendix of Exhibits in Support of Motion re 86 Initial Markman/Claim Construction Brief Apotex's Opening Markman Brief by APOTEX, INC. Part 2 - Ratain Claim Construction Report and Exs. 27-52, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit Ratain Ex. 28 - Lilly Amendment dated 12/23/04 (EP508 PH) (CC 390-401), # 2 Exhibit Ratain Ex. 29 - Examiner Action dated 5/17/05 (EP508 PH) (CC 402-06), # 3 Exhibit Ratain Ex. 30 - European Patent Convention, Article 123 (CC 407-08), # 4 Exhibit Ratain Ex. 31 - Initial Patent Claims dated 11/29/05 ( 807 Application) (CC 409-13), # 5 Exhibit Ratain Ex. 32 - Lilly Amendment dated 3/8/06 (EP508 Patent) (CC 414-50), # 6 Exhibit Ratain Ex. 33 - Lilly 065 Patent (CC 451-59), # 7 Exhibit Ratain Ex. 34 - Examiner Action dated 2/22/07 ( 807 PH) (CC 460-68), # 8 Exhibit Ratain Ex. 35 - Lilly EP508 Patent (CC 469-79), # 9 Exhibit Ratain Ex. 36 - Examiner Notes dated 8/22/07 ( 807 PH) (CC 480-80), # 10 Exhibit Ratain Ex. 37 - Notice of Abandonment dated 9/11/07 ( 807 PH) (CC 481-82), # 11 Exhibit Ratain Ex. 38 - Shih Publication dated 3/15/97 (CC 483-90), # 12 Exhibit Ratain Ex. 39 - John Publication dated 4/15/00 (CC 491-97), # 13 Exhibit Ratain Ex. 40 - Examiner Action dated 9/8/09 ( 209 PH) (CC 498-504), # 14 Exhibit Ratain Ex. 41 - Taylor 932 Patent dated 9/6/94 (CC 505-17), # 15 Exhibit Ratain Ex. 42 - Hanauske Publication dated 2001 (CC 518-28), # 16 Exhibit Ratain Ex. 43 - FDA Review dated 8/14/03 (CC 529-90), # 17 Exhibit Ratain Ex. 44 - Kuroda Publication dated 2000 (CC 591-95), # 18 Exhibit Ratain Ex. 45 - Methotrexate 1999 (CC 596-621), # 19 Exhibit Ratain Ex. 46 - Tularik 023 Publication (CC 622-41), # 20 Exhibit Ratain Ex. 47 - Lilly 974 Patent (CC 642-47), # 21 Exhibit SEALED Ratain Ex. 48 (CC 648-65), # 22 Exhibit Ratain Ex. 49 - Stedman s Medical Dictionary (1995) (CC 666-70), # 23 Exhibit Ratain Ex. 50 - American Heritage Medical Dictionary (2007) (CC 671-75), # 24 Exhibit Ratain Ex. 51 - Entry on Claim Construction dated 6/20/12 (Lilly v. Teva) (CC 676-97), # 25 Exhibit Ratain Ex. 52 - Excerpt of Chabner Report dated 3/21/17 (Lilly v. Dr. Reddy s) (CC 698-701))(Zweig, Sally) (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 92 | Appendix of Exhibits in Support of Motion re 86 Initial Markman/Claim Construction Brief Apotex's Opening Markman Brief by APOTEX, INC. Part 3 - Buckton Claim Construction Report and Appx 1-29, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit REDACTED Buckton Claim Construction Report (May 2018) (CC 702-91), # 2 Appendix Buckton Appx 1 - 209 Patent (CC 792-801), # 3 Appendix Buckton Appx 2 - Lilly 974 Patent (CC 802-07), # 4 Appendix Buckton Appx 3 - Taylor 932 Patent dated 9/6/94 (CC 808-20), # 5 Appendix Buckton Appx 4 - Shih Publication dated 3/15/97 (CC 821-28), # 6 Appendix Buckton Appx 5 - US Trademark Application dated 2/2/98 (CC 829-30), # 7 Appendix Buckton Appx 6 - EP Trademark Application dated 5/19/98 (CC 831-34), # 8 Appendix Buckton Appx 7 - Methotrexate 1999 (CC 835-60), # 9 Appendix Buckton Appx 8 - 254 Application ( 379 Publication) (CC 861-73), # 10 Appendix Buckton Appx 9 - 691 Application ( 365 Patent) (CC 874-87), # 11 Appendix Buckton Appx 10 - 964 Application ( 379 Publication) (CC 888-909), # 12 Appendix Buckton Appx 11 - John Publication dated 4/15/00 (CC 910-16), # 13 Appendix Buckton Appx 12 - 310 Application ( 209 Patent) (CC 917-32), # 14 Appendix Buckton Appx 13 - 599 Application ( 365 Patent) (CC 933-48), # 15 Appendix Buckton Appx 14 - 777 Application ( 379 Publication) (CC 949-89), # 16 Appendix Buckton Appx 15 - 859 Application ( 209 Patent) (CC 990-1006), # 17 Appendix Buckton Appx 16 - 648 Application ( 365 Patent) (CC 1007-20), # 18 Appendix Buckton Appx 17 - 486 Application ( 037 Publication) (CC 1021-31), # 19 Appendix Buckton Appx 18 - 379 Publication (CC 1032-70), # 20 Appendix Buckton Appx 19 - 448 application ( 209 Patent) (CC 1071-90), # 21 Appendix Buckton Appx 20 - 297 Application ( 037 Publication) (CC 1091-101), # 22 Appendix Buckton Appx 21 - 860 Application ( 209 PH) (CC 1102-22), # 23 Appendix Buckton Appx 22 - 233 Application ( 037 Publication) (CC 1123-36), # 24 Appendix Buckton Appx 23 - 037 Publication (CC 1137-47), # 25 Appendix Buckton Appx 24 - 379 Application ( 365 Patent) (CC 1148-63), # 26 Appendix Buckton Appx 25 - Tularik 023 Publication (CC 1164-83), # 27 Appendix Buckton Appx 26 - Initial EPO Claims dated 1/8/03 (EP508 PH) (CC 1184-91), # 28 Appendix Buckton Appx 27 - 083 Publication ( 365 Patent) (CC 1192-95), # 29 Appendix Buckton Appx 28 - 365 Patent (CC 1196-201), # 30 Appendix Buckton Appx 29 - Label 2004 (CC 1202-15))(Zweig, Sally) Modified on 6/25/2018 (JRB). (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 93 | Appendix of Exhibits in Support of Motion re 86 Initial Markman/Claim Construction Brief Apotex's Opening Markman Brief by APOTEX, INC. Part 4 - Buckton Claim Construction Report and Appx 30-58, filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix Buckton Appx 30 - Examiner Action dated 3/9/04 (EP508 PH) (CC 1216-21), # 2 Appendix Buckton Appx 31 - European Patent Convention, Article 84 (CC 1222-23), # 3 Appendix Buckton Appx 32 - Examiner Action dated 9/27/04 ( 065 PH) (CC 1224-34), # 4 Appendix Buckton Appx 33 - Lilly Amendment dated 12/23/04 (EP508 PH) (CC 1235-46), # 5 Appendix Buckton Appx 34 - Examiner Action dated 5/17/05 (EP508 PH) (CC 1247-51), # 6 Appendix Buckton Appx 35 - European Patent Convention, Article 123 (CC 1252-53), # 7 Appendix Buckton Appx 36 - Initial Patent Claims dated 11/29/05 ( 807 Application) (CC 1254-58), # 8 Appendix Buckton Appx 37 - Lilly Amendment dated 3/8/06 (EP508 Patent) (CC 1259-95), # 9 Appendix Buckton Appx 38 - Lilly 065 Patent (CC 1296-304), # 10 Appendix Buckton Appx 39 - Examiner Search Results dated 2/8/07 ( 807 Application) (CC 1305-28), # 11 Appendix Buckton Appx 40 - Examiner Search Results dated 2/12/07 ( 807 Application) (CC 1329-51), # 12 Appendix Buckton Appx 41 - Examiner Action dated 2/22/07 ( 807 PH) (CC 1352-60), # 13 Appendix Buckton Appx 42 - Lilly EP508 Patent (CC 1361-71), # 14 Appendix Buckton Appx 43 - Preliminary Amendment dated 7/11/07 ( 209 PH) (CC 1372-78), # 15 Appendix Buckton Appx 44 - Examiner Notes dated 8/22/07 ( 807 PH) (CC 1379), # 16 Appendix Buckton Appx 45 - Notice of Abandonment dated 9/11/07 ( 807 PH) (CC 1380-81), # 17 Appendix Buckton Appx 46 - Second Preliminary Amendment dated 12/8/08 ( 209 PH) (CC 1382-85), # 18 Appendix Buckton Appx 47 - Examiner Action dated 2/18/09 ( 209 PH) (CC 1386-94), # 19 Appendix Buckton Appx 48 - Lilly Response dated 5/4/09 ( 209 PH) (CC 1395-400), # 20 Appendix Buckton Appx 49 - Examiner Action dated 9/8/09 ( 209 PH) (CC 1401-07), # 21 Appendix Buckton Appx 50 - Lilly Response dated 11/13/09 ( 209 PH) (CC 1408-19), # 22 Appendix Buckton Appx 51 - Label 2009 ( 209 PH) (CC 1420-42), # 23 Appendix Buckton Appx 52 - Entry on Claim Construction dated 6/20/12 (Lilly v. Teva) (CC 1443-64), # 24 Appendix Buckton Appx 53 - Excerpt of Chabner Report dated 3/21/17 (Lilly v. Dr. Reddy s) (CC 1465-68), # 25 Appendix Buckton Appx 54 - Excerpt of Oral Argument dated 11/2017 (Lilly v. Dr. Reddy s) (CC 1469-75), # 26 Appendix Buckton Appx 55 - CAS Registry No. 137281-23-3 dated 3/30/18 (CC 1476-80), # 27 Appendix Buckton Appx 56 - CAS Registry No. 150399-23-8 dated 3/30/18 (CC 1481-84), # 28 Appendix Buckton Appx 57 - Dosage Forms dated 3/27/18 (CC 1485-91), # 29 Appendix SEALED Buckton Appx 58 (CC 1492-508))(Zweig, Sally) (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 94 | SEALED , re 93 Appendix of Exhibits in Support, 91 Appendix of Exhibits in Support, 92 Appendix of Exhibits in Support, 90 Appendix of Exhibits in Support, filed by Defendant APOTEX, INC.. (Attachments: # 1 Appendix SEALED Appendix to Apotex's Opening Markman Brief, # 2 Exhibit SEALED Ratain Claim Construction Report (May 2018) (CC_1-88), # 3 Exhibit SEALED Ratain Ex. 48 (CC_648-65), # 4 Exhibit SEALED Buckton Claim Construction Report (May 2018) (CC_702-91), # 5 Exhibit SEALED Buckton Appx 58 (CC_1492-508))(Zweig, Sally) Modified on 6/19/2018 (TRG). (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 95 | Unopposed MOTION to Maintain Document Under Seal 94 SEALED Document (Case Participants - doc) Apotexs Opening Markman Brief, Ratain Claim Construction Report, Buckton Claim Construction Report, Ratain Exhibit 48, and Buckton Appx 58, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 06/19/2018) (0) |
Jun 19, 2018 | 96 | BRIEF/MEMORANDUM in Support re 95 Unopposed MOTION to Maintain Document Under Seal 94 SEALED Document (Case Participants - doc) Apotexs Opening Markman Brief, Ratain Claim Construction Report, Buckton Claim Construction Report, Ratain Exhibit 48, and Buckton Appx 58 , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 06/19/2018) (5) |
May 29, 2018 | 85 | Joint Claim Construction Statement , filed by Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 05/29/2018) (9) |
May 8, 2018 | 84 | ORDER granting 81 Motion to Maintain Document 80 Under Seal - A redacted public version of the document shall be available on the docket 83 . Signed by Magistrate Judge Matthew P. Brookman on 5/8/2018. (JRB) (Entered: 05/08/2018) (1) |
May 7, 2018 | 80 | SEALED , filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Amended and Supplemented Preliminary Witness & Exhibit List)(Zweig, Sally) (Entered: 05/07/2018) (0) |
May 7, 2018 | 81 | Unopposed MOTION to Maintain Document Under Seal 80 SEALED Document (Case Participants - doc) Apotex's Amended and Supplemented Preliminary Witness & Exhibit List, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 05/07/2018) (0) |
May 7, 2018 | 82 | BRIEF/MEMORANDUM in Support re 81 Unopposed MOTION to Maintain Document Under Seal 80 SEALED Document (Case Participants - doc) Apotex's Amended and Supplemented Preliminary Witness & Exhibit List , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 05/07/2018) (5) |
May 7, 2018 | 83 | REDACTION to 80 SEALED Document (Case Participants - doc) Apotex's Amended and Supplemented Preliminary Witness & Exhibit List by APOTEX, INC.. (Zweig, Sally) (Entered: 05/07/2018) (8) |
May 2, 2018 | 79 | NOTICE of Appearance by Dov P. Grossman on behalf of Plaintiff ELI LILLY AND COMPANY, Counter Defendant ELI LILLY AND COMPANY. (Grossman, Dov) (Entered: 05/02/2018) (2) |
May 1, 2018 | 78 | ORDER - granting 77 Joint Motion to Extend Deadlines in the Claim Construction Schedule (ECF 69). (See Order for established deadlines.) Signed by Judge Tanya Walton Pratt on 5/1/2018. (NAD) (Entered: 05/01/2018) (2) |
Apr 27, 2018 | 77 | Joint MOTION to Extend Deadlines in the Claim Construction Schedule, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 04/27/2018) (0) |
Apr 26, 2018 | 75 | SCHEDULING ORDER - Final Pretrial Conference set for 7/3/2019 at 11:00 AM in room #330, United States Courthouse, 46 E. Ohio Street, Indianapolis, Indiana before Judge Tanya Walton Pratt. Bench Trial set for 7/29/2019 at 9:00 AM in room #344, United States Courthouse, 46 E. Ohio Street, Indianapolis, Indiana before Judge Tanya Walton Pratt. The final pretrial conference is for attorneys only. At the final pretrial conference, Counsel shall be prepared to discuss the status of the action, including all matters requiring completion preparatory to trial. Signed by Judge Tanya Walton Pratt on 4/26/2018.(NAD) (Entered: 04/26/2018) (2) |
Apr 26, 2018 | 76 | TRIAL PROCEDURES AND PRACTICES before Judge Tanya Walton Pratt. (NAD) (Entered: 04/26/2018) (14) |
Apr 3, 2018 | 74 | ORDER granting 73 Motion to Withdraw Attorney Appearance. Attorney Patrick C. Kilgore withdrawn. Signed by Judge Tanya Walton Pratt on 4/3/2018. (NAD) (Entered: 04/03/2018) (1) |
Apr 2, 2018 | 73 | MOTION to Withdraw Attorney Appearance [MOTION FOR LEAVE TO WITHDRAW APPEARANCE OF ATTORNEY PATRICK C. KILGORE], filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 04/02/2018) (0) |
Mar 29, 2018 | 72 | ORDER granting 71 Motion to Appear pro hac vice. Attorney Cynthia Sun for APOTEX, INC.,Cynthia Sun for APOTEX, INC. added. Signed by Magistrate Judge Matthew P. Brookman on 3/29/2018. (JRB) (Entered: 03/29/2018) (2) |
Mar 27, 2018 | 70 | NOTICE of Withdrawal of Appearance by Patrick C. Kilgore on behalf of APOTEX, INC. (Zweig, Sally) (Entered: 03/27/2018) (2) |
Mar 27, 2018 | 71 | MOTION for Attorney(s) Cynthia H. Sun to Appear pro hac vice (Filing fee $100, receipt number 0756-4816116), filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A- Certification of Cynthia H. Sun, # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 03/27/2018) (0) |
Mar 5, 2018 | 69 | SCHEDULING ORDER:- The Plaintiff Eli Lilly and Company's and Defendant Apotex, Inc.'s joint Proposed Claim Construction Schedule (Filing No. 68) is GRANTED. Markman Hearing set for 9/17/2018 at 9:00 AM (Eastern Time) in room #344, United States Courthouse, 46 E. Ohio Street, Indianapolis, Indiana before Judge Tanya Walton Pratt. See entry for details. Signed by Judge Tanya Walton Pratt on 3/5/2018. (MEJ) (Entered: 03/05/2018) (4) |
Mar 1, 2018 | 68 | Submission Parties' Joint Submission of a Proposed Claim Construction Schedule, filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 03/01/2018) (3) |
Feb 27, 2018 | 67 | MINUTE ORDER for proceedings held before Magistrate Judge Matthew P. Brookman: Status Conference held on 2/27/2018. Parties were represented by counsel. No further orders are entered at this time. Signed by Magistrate Judge Matthew P. Brookman. (TMB) (Entered: 02/27/2018) (1) |
Feb 23, 2018 | 66 | NOTICE of Appearance by Deborah Pollack-Milgate on behalf of Plaintiff ELI LILLY AND COMPANY. (Pollack-Milgate, Deborah) (Entered: 02/23/2018) (2) |
Feb 5, 2018 | 64 | NOTICE of Appearance by Alec T. Swafford on behalf of Plaintiff ELI LILLY AND COMPANY, Counter Defendant ELI LILLY AND COMPANY. (Swafford, Alec) (Entered: 02/05/2018) (2) |
Jan 30, 2018 | 63 | MARGINAL ENTRY - 43 Motion for Claim Construction is granted. Parties are to confer and submit a proposed claim construction schedule. Parties may contact the Magistrate Judge if his assistance is needed in determining the schedule. Signed by Judge Tanya Walton Pratt on 1/30/2018. (MEJ) (Entered: 01/30/2018) (1) |
Jan 26, 2018 | 59 | ORDER granting 40 Motion to Maintain Document 39 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 1/26/2018. (JRB) (Entered: 01/26/2018) (1) |
Jan 26, 2018 | 60 | ORDER granting 45 Motion to Maintain Document 44 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 1/26/2018. (JRB) (Entered: 01/26/2018) (1) |
Jan 26, 2018 | 61 | ORDER granting 52 Motion to Maintain Document 51 Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 1/26/2018. (JRB) (Entered: 01/26/2018) (1) |
Jan 26, 2018 | 62 | ORDER granting 54 Motion to Maintain 53 Document Under Seal. Signed by Magistrate Judge Matthew P. Brookman on 1/26/2018. (JRB) (Entered: 01/26/2018) (1) |
Jan 25, 2018 | 58 | REPLY in Support of Motion re 52 MOTION to Maintain Document Under Seal 51 SEALED Response to Motion for Claim Construction Proceeding APOTEXS BRIEF IN SUPPORT OF LILLYS MOTION TO FILE AND PROVISIONALLY MAINTAIN UNDER SEAL LILLYS OPPOSITION TO APOTEXS MOTION FOR CLAIM CONSTRUCTION PROCEEDING, filed by Defendant APOTEX, INC.. (Attachments: # 1 REDACTED Dkt 51 (Plaintiff's Opposition to Defendant's Motion for Claim Construction Proceeding), # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 01/25/2018) (0) |
Jan 19, 2018 | 57 | NOTICE of Initial Extension of Time to Respond to Plaintiff's First Set of Interrogatories and First Requests for Production of Documents and Things, filed by Defendant APOTEX, INC. (Zweig, Sally) (Entered: 01/19/2018) (3) |
Jan 18, 2018 | 53 | SEALED REPLY in support of Motion re 43 MOTION APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING , filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Reply Brief in Support of Apotex's Rule16(B)(4) Motion for Claim Construction Proceeding)(Zweig, Sally) (Entered: 01/18/2018) (0) |
Jan 18, 2018 | 54 | Unopposed MOTION to Maintain Document Under Seal 53 SEALED Reply in support of Motion APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 01/18/2018) (0) |
Jan 18, 2018 | 55 | BRIEF/MEMORANDUM in Support re 54 Unopposed MOTION to Maintain Document Under Seal 53 SEALED Reply in support of Motion APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 01/18/2018) (5) |
Jan 18, 2018 | 56 | REDACTION to 53 SEALED Reply in support of Motion APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING by APOTEX, INC.. (Zweig, Sally) (Entered: 01/18/2018) (17) |
Jan 11, 2018 | 51 | SEALED RESPONSE re 43 MOTION APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING , filed by Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 01/11/2018) (0) |
Jan 11, 2018 | 52 | MOTION to Maintain Document Under Seal 51 SEALED Response to Motion for Claim Construction Proceeding, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Text of Proposed Order)(Fomenkova, Galina) (Entered: 01/11/2018) (0) |
Dec 27, 2017 | 49 | ORDER granting 38 Motion to Appear pro hac vice. Attorney Xiaomei Cai for APOTEX, INC.,Xiaomei Cai for APOTEX, INC. added. Signed by Magistrate Judge Matthew P. Brookman on 12/27/2017. (JRB) (Entered: 12/27/2017) (1) |
Dec 27, 2017 | 50 | ORDER granting 48 Motion for Extension of Time to File Response to 1/11/2018 re 43 MOTION for Claim Construction Proceeding. Signed by Judge Tanya Walton Pratt on 12/27/2017. (JD) (Entered: 12/28/2017) (1) |
Dec 22, 2017 | 43 | MOTION APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/22/2017) (0) |
Dec 22, 2017 | 44 | SEALED , re 43 Motion (Other), filed by Defendant APOTEX, INC.. (Attachments: # 1 SEALED Brief in Support of APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING, # 2 Exhibit 12 - SEALED March 2001 Application, # 3 Exhibit 13 - SEALED Apotex Notice Letter)(Zweig, Sally) (Entered: 12/22/2017) (0) |
Dec 22, 2017 | 45 | Unopposed MOTION to Maintain Document Under Seal 44 SEALED Document (Case Participants - doc) APOTEXS UNOPPOSED MOTION TO FILE AND MAINTAIN UNDER SEAL APOTEXS MEMORANDUM IN SUPPORT OF, AND EXHIBITS 12 AND 13 TO, APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/22/2017) (0) |
Dec 22, 2017 | 46 | BRIEF/MEMORANDUM in Support re 45 Unopposed MOTION to Maintain Document Under Seal 44 SEALED Document (Case Participants - doc) APOTEXS UNOPPOSED MOTION TO FILE AND MAINTAIN UNDER SEAL APOTEXS MEMORANDUM IN SUPPORT OF, AND EXHIBITS 12 AND 13 TO, APOTEXS RULE 16(B)(4) MOTION F , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 12/22/2017) (5) |
Dec 22, 2017 | 47 | REDACTION to 44 SEALED Document (Case Participants - doc) by APOTEX, INC.. (Attachments: # 1 Exhibit 1- Order, # 2 Exhibit 2 - November 9 Transcript, # 3 Exhibit 3-Eagle Order, # 4 Exhibit 4-Teva CMP, # 5 Exhibit 5-Teva Docket, # 6 Exhibit 6-Teva Docket, # 7 Exhibit 7-DRL Opening Brief, # 8 Exhibit 8-Lilly Opposition, # 9 Exhibit 9- DRL Reply, # 10 Exhibit 10-UK Supreme Court Decision, # 11 Exhibit 11-UK Trial Court Decision, # 12 Exhibit 12 - REDACTED March 2001 Application, # 13 Exhibit 13-REDACTED Apotex Notice Letter, # 14 Exhibit 14-Meet/Confer, # 15 Exhibit 15-West Liberty v. Perdue)(Zweig, Sally) (Entered: 12/22/2017) (0) |
Dec 22, 2017 | 48 | Unopposed MOTION for Extension of Time to File Response to 01/11/2018 re 43 MOTION APOTEXS RULE 16(B)(4) MOTION FOR CLAIM CONSTRUCTION PROCEEDING , filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Proposed Order)(Lemens, Andrew) (Entered: 12/22/2017) (0) |
Dec 21, 2017 | 38 | MOTION for Attorney(s) Xiaomei Cai to Appear pro hac vice (Filing fee $100, receipt number 0756-4683081), filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit Certification of Xiaomei Cai, # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 12/21/2017) (0) |
Dec 21, 2017 | 39 | SEALED Preliminary Witness LIST & Exhibit Lists, filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit SEALED Preliminary Witness List & Exhibit List)(Zweig, Sally) (Entered: 12/21/2017) (0) |
Dec 21, 2017 | 40 | Unopposed MOTION to Maintain Document Under Seal 39 SEALED Document (Case Participants - doc) Preliminary Witness & Exhibit Lists, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) (Entered: 12/21/2017) (0) |
Dec 21, 2017 | 41 | BRIEF/MEMORANDUM in Support re 40 Unopposed MOTION to Maintain Document Under Seal 39 SEALED Document (Case Participants - doc) Preliminary Witness & Exhibit Lists , filed by Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 12/21/2017) (5) |
Dec 21, 2017 | 42 | REDACTION to 39 SEALED Document (Case Participants - doc) Preliminary Witness & Exhibit Lists by APOTEX, INC.. (Zweig, Sally) (Entered: 12/21/2017) (7) |
Dec 18, 2017 | 37 | NOTICE of Answer in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Answer) (MEJ) (Entered: 12/18/2017) (0) |
Dec 14, 2017 | 36 | Witness List (Preliminary), filed by Plaintiff ELI LILLY AND COMPANY, Exhibit List (Preliminary), filed by Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 12/14/2017) (6) |
Dec 12, 2017 | 34 | STIPULATED PROTECTIVE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 12/12/2017.(JRB) (Entered: 12/12/2017) (21) |
Dec 12, 2017 | 35 | ANSWER to 28 Answer to ComplaintCounterclaim , filed by ELI LILLY AND COMPANY.(Fomenkova, Galina) (Entered: 12/12/2017) (30) |
Dec 8, 2017 | 33 | Motion for Stipulated Protective Order, filed by Plaintiff ELI LILLY AND COMPANY. (Attachments: # 1 Exhibit A - Agreement to Be Bound by Protective Order)(Fomenkova, Galina) Modified on 12/11/2017 to correctly identify event (MEJ). (Entered: 12/08/2017) (0) |
Dec 7, 2017 | 32 | ORDER: CASE MANAGEMENT PLAN APPROVED AS AMENDED. Initial Pretrial Conference held on 12/4/2017. Discovery due by 8/20/2018. Status Conference set for 2/27/2018 at 12:00 PM (Eastern Time) in Telephonic before Magistrate Judge Matthew P. Brookman. Signed by Magistrate Judge Matthew P. Brookman on 12/5/2017.(TMB) (Entered: 12/07/2017) (18) |
Nov 27, 2017 | 29 | NOTICE of Answer in lawsuit sent to Director of U.S. Patent and Trademark Office. (Attachments: # 1 Answer) (MEJ) (Entered: 11/27/2017) (0) |
Nov 27, 2017 | 30 | CASE MANAGEMENT PLAN TENDERED, filed by Plaintiff ELI LILLY AND COMPANY . (Fomenkova, Galina) (Entered: 11/27/2017) (18) |
Nov 21, 2017 | 28 | [APOTEX'S ANSWER, DEFENSES, AND COUNTERCLAIMS] ANSWER to 1 Complaint , COUNTERCLAIM against ELI LILLY AND COMPANY, filed by APOTEX, INC..(Zweig, Sally) (Entered: 11/21/2017) (30) |
Nov 17, 2017 | 27 | NOTICE of Appearance by Andrew Lemens on behalf of Plaintiff ELI LILLY AND COMPANY. (Lemens, Andrew) (Entered: 11/17/2017) (2) |
Oct 17, 2017 | 26 | ORDER granting 24 Motion for Extension of Time to Respond to Complaint to 11/21/17. Signed by Magistrate Judge Matthew P. Brookman on 10/17/2017. (JRB) (Entered: 10/17/2017) (1) |
Oct 16, 2017 | 25 | ORDER SETTING INITIAL PRE-TRIAL CONFERENCE - Initial Telephonic Pretrial Conference set for 12/4/2017 at 11:00 AM (Eastern Time) before Magistrate Judge Matthew P. Brookman. The information needed to participate in this telephonic conference will be provided by a separate notification. No fewer than seven (7) days before the IPTC, counsel must file a proposed CMP. **The Court notes that the proposed CMP has been filed.** SEE ORDER. Signed by Magistrate Judge Matthew P. Brookman on 10/16/2017.(JRB) (Entered: 10/16/2017) (2) |
Oct 13, 2017 | 23 | Corporate Disclosure Statement by APOTEX, INC. identifying Corporate Parent APOTEX HOLDINGS, INC. for APOTEX, INC. (Zweig, Sally) Modified on 10/16/2017 to clarify (MEJ). (Entered: 10/13/2017) (3) |
Oct 13, 2017 | 24 | Unopposed MOTION for Extension of Time to Answer, Move, or Othwerwise Respond to Complaint, filed by Defendant APOTEX, INC.. (Attachments: # 1 Text of Proposed Order)(Zweig, Sally) Modified on 10/16/2017 to correctly identify event (MEJ). (Entered: 10/13/2017) (0) |
Sep 28, 2017 | 19 | ORDER granting 14 Motion to Appear pro hac vice. Attorney William A. Rakoczy for APOTEX, INC. added. Copy sent to Counsel via US Mail. Signed by Magistrate Judge Matthew P. Brookman on 9/28/2017. (JRB) (Entered: 09/28/2017) (1) |
Sep 28, 2017 | 20 | ORDER granting 15 Motion to Appear pro hac vice. Attorney Joseph T. Jaros for APOTEX, INC. added. Signed by Magistrate Judge Matthew P. Brookman on 9/28/2017. (JRB) (Entered: 09/28/2017) (1) |
Sep 28, 2017 | 21 | ORDER granting 16 Motion to Appear pro hac vice. Attorney Patrick C. Kilgore for APOTEX, INC. added. Signed by Magistrate Judge Matthew P. Brookman on 9/28/2017. (JRB) (Entered: 09/28/2017) (1) |
Sep 28, 2017 | 22 | NOTICE of Change of Attorney Information. Consistent with Local Rule 5-3, Kathryn Elias Cordell hereby notifies the Clerk of the court of changed contact information. (Cordell, Kathryn) (Entered: 09/28/2017) (1) |
Sep 27, 2017 | 13 | NOTICE of Appearance by Sally F. Zweig on behalf of Defendant APOTEX, INC.. (Zweig, Sally) (Entered: 09/27/2017) (3) |
Sep 27, 2017 | 14 | MOTION for Attorney(s) William A. Rakoczy to Appear pro hac vice (Filing fee $100, receipt number 0756-4558606), filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A-Certification of William A. Rakoczy, # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 09/27/2017) (0) |
Sep 27, 2017 | 15 | MOTION for Attorney(s) Joseph T. Jaros to Appear pro hac vice (Filing fee $100, receipt number 0756-4558612), filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A-Certification of Joseph T. Jaros, # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 09/27/2017) (0) |
Sep 27, 2017 | 16 | MOTION for Attorney(s) Patrick C. Kilgore to Appear pro hac vice (Filing fee $100, receipt number 0756-4558620), filed by Defendant APOTEX, INC.. (Attachments: # 1 Exhibit A-Certification of Patrick C. Kilgore, # 2 Text of Proposed Order)(Zweig, Sally) (Entered: 09/27/2017) (0) |
Sep 27, 2017 | 17 | NOTICE of Appearance by Kristopher N. Kazmierczak on behalf of Defendant APOTEX, INC.. (Kazmierczak, Kristopher) (Entered: 09/27/2017) (3) |
Sep 27, 2017 | 18 | NOTICE of Appearance by Kathryn Elias Cordell on behalf of Defendant APOTEX, INC.. (Cordell, Kathryn) (Entered: 09/27/2017) (3) |
Sep 20, 2017 | 10 | NOTICE of Appearance by Adam L. Perlman on behalf of Plaintiff ELI LILLY AND COMPANY. (Perlman, Adam) (Entered: 09/20/2017) (2) |
Sep 20, 2017 | 11 | NOTICE of Appearance by David M. Krinsky on behalf of Plaintiff ELI LILLY AND COMPANY. (Krinsky, David) (Entered: 09/20/2017) (2) |
Sep 20, 2017 | 12 | NOTICE of Appearance by Galina I. Fomenkova on behalf of Plaintiff ELI LILLY AND COMPANY. (Fomenkova, Galina) (Entered: 09/20/2017) (2) |
Sep 13, 2017 | 8 | ORDER REASSIGNING CASE. Clerk is directed to reassign case to Judge Tanya Walton Pratt and Magistrate Judge Matthew P. Brookman for all further proceedings. This case is related to 1:16-cv-308-TWP-MPB. Judge William T. Lawrence and Magistrate Judge Debra McVicker Lynch no longer assigned to case. Signed by Judge William T. Lawrence on 9/13/2017. (CMC) (Entered: 09/13/2017) (1) |
Sep 13, 2017 | 9 | NOTICE of Reassignment of Case to Judge Tanya Walton Pratt and Magistrate Judge Matthew P. Brookman. Judge William T. Lawrence, Magistrate Judge Debra McVicker Lynch no longer assigned to the case. Please include the new case number, 1:17-cv-2865-TWP-MPB, on all future filings in this matter. (MEH) (Entered: 09/13/2017) (1) |
Aug 28, 2017 | 7 | WAIVER OF SERVICE Returned Executed, filed by ELI LILLY AND COMPANY. APOTEX, INC. waiver sent on 8/25/2017. (DePrez, Anne) (Entered: 08/28/2017) (1) |
Aug 23, 2017 | 6 | Summons Issued as to APOTEX, INC.. (MEH) (Entered: 08/23/2017) (1) |
Aug 22, 2017 | 5 | MAGISTRATE JUDGE's NOTICE of Availability to Exercise Jurisdiction issued. (NAD) (Entered: 08/22/2017) (1) |
Aug 21, 2017 | 2 | NOTICE of Appearance by Anne N. DePrez on behalf of Plaintiff ELI LILLY AND COMPANY. (DePrez, Anne) (Entered: 08/21/2017) (1) |
Aug 21, 2017 | 3 | Corporate Disclosure Statement by ELI LILLY AND COMPANY. (DePrez, Anne) (Entered: 08/21/2017) (1) |
Aug 21, 2017 | 4 | NOTICE OF RELATED CASE, filed by Plaintiff ELI LILLY AND COMPANY (DePrez, Anne) (Entered: 08/21/2017) (2) |
Aug 21, 2017 | 1 | Complaint* (1) |